Visible node/edge number:
Node colors:
Node labels:

show label of nodes with degree >=

Node sizes:
Edge colors:
Edge widths factor:
Layout:

gravity >=

edgeLength =

GRN in network:

Notice: IE browser need to manually refresh (F5) this page after resetting the network.

This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.

"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.

miRNA-gene regulations

(Download full result)

Num microRNA           Gene miRNA log2FC miRNA pvalue Gene log2FC Gene pvalue Interaction Correlation beta Correlation P-value PMID Reported in cancer studies
1 hsa-miR-106a-5p AR -0.46 0.00972 -2.66 0 mirMAP -0.48 2.0E-5 NA
2 hsa-miR-106b-5p AR 0.65 0 -2.66 0 mirMAP -1.42 0 NA
3 hsa-miR-125a-3p AR -0.84 4.0E-5 -2.66 0 miRNATAP -0.51 0 NA
4 hsa-miR-132-3p AR 0.32 0.00272 -2.66 0 mirMAP -1.03 0 NA
5 hsa-miR-136-3p AR -1.37 0 -2.66 0 mirMAP -0.15 0.03902 NA
6 hsa-miR-136-5p AR -1.19 1.0E-5 -2.66 0 miRNATAP -0.17 0.0221 NA
7 hsa-miR-141-3p AR -0.35 0.257 -2.66 0 mirMAP -0.41 0 26062412; 22314666 miR 141 3p regulates the expression of androgen receptor by targeting its 3'UTR in prostate cancer LNCaP cells; After prostate cancer cell line LNCaP was transfected with miR-141-3p mimics expression levels of AR mRNA and protein in the LNCaP cells were detected by reverse transcription PCR and Western blotting respectively; The 3'untranslated regions 3'UTR of AR mRNA containing the binding site of miR-141-3p was amplified by PCR and inserted into pmiR-report vector a 3'downstream luciferase reporter gene; Transfection of miR-141-3p mimics decreased both mRNA and protein expression levels of AR in LNCaP cells; AR is a direct target gene of miR-141-3p;miR 141 modulates androgen receptor transcriptional activity in human prostate cancer cells through targeting the small heterodimer partner protein; Here we investigated the correlation of Shp expression with the cellular level of miR-141 and its effects on AR transcriptional activity in non-malignant and malignant human prostate epithelial cell lines; Phenethyl isothiocyanate a natural constituent of many edible cruciferous vegetables increased Shp expression downregulated miR-141 and inhibited AR transcriptional activity in LNCaP cells; Shp is a target for miR-141 and it is downregulated in cultured human PCa cells with the involvement of upregulation of miR-141 which promotes AR transcriptional activity
8 hsa-miR-146a-5p AR -0.74 0.00077 -2.66 0 mirMAP -0.42 0 25123132 To study the cellular response to miR-146a upregulation in p53-impaired basal-like lines antagomir KD of miR-146a was performed; KD of miR-146a caused decreased proliferation and increased apoptosis effectively ablating the effects of p53 loss
9 hsa-miR-148b-3p AR 0.27 0.00185 -2.66 0 mirMAP -0.99 3.0E-5 NA
10 hsa-miR-148b-5p AR 0.3 0.02557 -2.66 0 mirMAP -0.82 0 NA
11 hsa-miR-149-5p AR -0.32 0.18721 -2.66 0 miRNATAP -0.35 3.0E-5 NA
12 hsa-miR-155-5p AR 0.01 0.95651 -2.66 0 mirMAP -0.47 0 NA
13 hsa-miR-17-5p AR 0.7 2.0E-5 -2.66 0 mirMAP -0.93 0 23095762 miR 17 5p targets the p300/CBP associated factor and modulates androgen receptor transcriptional activity in cultured prostate cancer cells; Targeting of the 3'-untranslated region of PCAF mRNA by miR-17-5p caused translational suppression and RNA degradation and consequently modulation of AR transcriptional activity in PCa cells; Targeting of PCAF by miR-17-5p modulates AR transcriptional activity and cell growth in cultured PCa cells
14 hsa-miR-181a-5p AR 0.25 0.05519 -2.66 0 miRNATAP -1.23 0 NA
15 hsa-miR-181b-5p AR 0.49 0.00105 -2.66 0 miRNATAP -1.3 0 NA
16 hsa-miR-181c-5p AR -0.01 0.96913 -2.66 0 miRNATAP -0.78 0 NA
17 hsa-miR-185-5p AR 0.48 0 -2.66 0 miRNAWalker2 validate; MirTarget -0.56 0.00776 25673182; 26940039; 23417242 MicroRNA 185 downregulates androgen receptor expression in the LNCaP prostate carcinoma cell line;MMTV-Fluc reporter assays revealed that miR-185 can attenuate AR function by suppressing BRD8 ISO2;MicroRNA 185 suppresses proliferation invasion migration and tumorigenicity of human prostate cancer cells through targeting androgen receptor; Targets prediction revealed that AR had putative complementary sequences to miR-185 which was confirmed by the following dual luciferase reporter assay; Overexpression of miR-185 could reduce the expression of AR protein but not mRNA in LNCaP cells; CDC6 one target of AR and an important regulatory molecule for cell cycle was found to be down-regulated by overexpression of miR-185; Our findings suggest that miR-185 could function as a tumor-suppressor gene in CaP by directly targeting AR and act as a potential therapeutic target for CaP
18 hsa-miR-19a-3p AR 1.02 0 -2.66 0 mirMAP -0.6 0 NA
19 hsa-miR-19b-3p AR 0.6 0.00017 -2.66 0 mirMAP -0.68 0 NA
20 hsa-miR-200a-3p AR -1.5 3.0E-5 -2.66 0 mirMAP -0.32 0 24391862 We identified miR-200 b as a downstream target of androgen receptor and linked its expression to decreased tumorigenicity and metastatic capacity of the prostate cancer cells
21 hsa-miR-200a-5p AR -1.17 0.00105 -2.66 0 miRNATAP -0.33 0 24391862 We identified miR-200 b as a downstream target of androgen receptor and linked its expression to decreased tumorigenicity and metastatic capacity of the prostate cancer cells
22 hsa-miR-20a-5p AR 0.85 0 -2.66 0 mirMAP -0.73 0 NA
23 hsa-miR-20b-5p AR 0.46 0.02859 -2.66 0 mirMAP -0.37 0.00012 NA
24 hsa-miR-212-3p AR -0.29 0.10039 -2.66 0 mirMAP -0.44 0.00013 26553749 Aberrant coexpression of AR and hnRNPH1 and downregulation of miR-212 were detected in prostate tumors and correlate with disease progression in AA men compared with CA men; Ectopic expression of miR-212 mimics downregulated hnRNPH1 transcripts which in turn reduced expression of AR and its splice variant AR-V7 or AR3 in prostate cancer cells
25 hsa-miR-223-3p AR -1 0 -2.66 0 mirMAP -0.27 0.00947 NA
26 hsa-miR-2355-3p AR -0.47 0.00719 -2.66 0 mirMAP -0.43 0.00022 NA
27 hsa-miR-2355-5p AR -0.23 0.15791 -2.66 0 MirTarget -0.44 0.00037 NA
28 hsa-miR-301a-3p AR 0.84 0 -2.66 0 mirMAP; miRNATAP -1.06 0 25940439 Mechanism dissection revealed infiltrating pre-adipocytes might function through down-regulation of the androgen receptor AR via modulation of miR-301a and then increase PCa cell invasion via induction of TGF-β1/Smad/MMP9 signals
29 hsa-miR-30d-5p AR 0.72 0 -2.66 0 mirMAP -0.36 0.01974 27683042 Inhibition of endogenous miR-30b-3p and miR-30d-5p enhanced AR expression and androgen-independent cell growth; MiR-30d-5p levels were inversely correlated with AR activity as measured by PSA mRNA in metastatic CRPC
30 hsa-miR-320a AR 0.33 0.02214 -2.66 0 miRNATAP -0.42 0.00334 27216188 Histone Deacetylase Inhibition in Prostate Cancer Triggers miR 320 Mediated Suppression of the Androgen Receptor; Among the upregulated miRNAs after OBP-801 treatment in the three prostate cancer cell lines miR-320a whose expression was significantly correlated with prognosis of prostate cancers P = 0.0185 was the most closely associated with AR expression; An miR-320a mimic suppressed AR protein expression together with growth suppression while anti-miR-320a oligonucleotide significantly abrogated the growth suppression by OBP-801 treatment; Our data demonstrated that OBP-801 effectively suppressed AR activity via epigenetic upregulation of miR-320a which resulted in tumor cell growth suppression of prostate cancers
31 hsa-miR-335-3p AR -0.28 0.10663 -2.66 0 mirMAP -0.65 0 NA
32 hsa-miR-338-3p AR 0.54 0.00461 -2.66 0 miRanda -0.73 0 NA
33 hsa-miR-362-3p AR 0.81 0 -2.66 0 miRanda -0.3 0.03894 NA
34 hsa-miR-370-3p AR -1 0.00018 -2.66 0 MirTarget -0.23 0.00209 NA
35 hsa-miR-421 AR 0.94 0 -2.66 0 MirTarget; miRNATAP -0.67 0 26827675 A transcriptional target of androgen receptor miR 421 regulates proliferation and metabolism of prostate cancer cells; Expression of miR-421 was significantly suppressed by androgen treatment and correlated to AR expression in different prostate cancer cell lines; Furthermore androgen-activated AR could directly bind to androgen responsive element ARE of miR-421 as predicted by bioinformatics resources and demonstrated by ChIP and luciferase reporter assays
36 hsa-miR-429 AR -1.4 7.0E-5 -2.66 0 miRNATAP -0.3 0 NA
37 hsa-miR-432-5p AR -0.54 0.07486 -2.66 0 mirMAP -0.26 0.00013 NA
38 hsa-miR-452-3p AR 1.77 0 -2.66 0 mirMAP -0.21 0.00253 NA
39 hsa-miR-454-3p AR 0.67 0 -2.66 0 mirMAP; miRNATAP -0.87 0 NA
40 hsa-miR-493-5p AR -0.2 0.50287 -2.66 0 miRNATAP -0.28 4.0E-5 NA
41 hsa-miR-502-5p AR 0.89 0 -2.66 0 mirMAP -0.44 7.0E-5 NA
42 hsa-miR-629-3p AR -0.32 0.11909 -2.66 0 mirMAP -0.39 0.00013 NA
43 hsa-miR-660-5p AR 0.99 0 -2.66 0 mirMAP -0.4 0.00761 NA
44 hsa-miR-877-5p AR 1.36 0 -2.66 0 MirTarget -0.92 0 NA
45 hsa-miR-9-5p AR 1.26 9.0E-5 -2.66 0 miRNATAP -0.21 0.00072 NA
46 hsa-miR-93-5p AR 1.4 0 -2.66 0 mirMAP -1.11 0 NA

Over-represented Gene Ontology Biological Process

NumGOOverlapSizeP ValueAdj. P Value
1 POSITIVE REGULATION OF BIOSYNTHETIC PROCESS 117 1805 1.153e-29 2.682e-26
2 RESPONSE TO ENDOGENOUS STIMULUS 104 1450 1.038e-29 2.682e-26
3 REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 115 1784 6.778e-29 1.051e-25
4 CELL CYCLE 96 1316 7.405e-28 6.891e-25
5 REGULATION OF CELL PROLIFERATION 103 1496 5.966e-28 6.891e-25
6 NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS 101 1517 3.196e-26 2.479e-23
7 REGULATION OF CELL DEATH 99 1472 5.202e-26 3.458e-23
8 REGULATION OF CELL CYCLE 78 949 9.344e-26 5.435e-23
9 REGULATION OF BINDING 44 283 1.33e-25 6.877e-23
10 POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 86 1152 1.565e-25 7.284e-23
11 NEGATIVE REGULATION OF GENE EXPRESSION 98 1493 6.25e-25 2.644e-22
12 PEPTIDYL AMINO ACID MODIFICATION 71 841 4.179e-24 1.62e-21
13 CELL CYCLE PROCESS 80 1081 1.824e-23 6.53e-21
14 RESPONSE TO HORMONE 72 893 2.93e-23 9.197e-21
15 RESPONSE TO ORGANIC CYCLIC COMPOUND 73 917 2.965e-23 9.197e-21
16 CELLULAR RESPONSE TO ORGANIC SUBSTANCE 107 1848 5.736e-23 1.668e-20
17 POSITIVE REGULATION OF GENE EXPRESSION 103 1733 6.49e-23 1.749e-20
18 MITOTIC CELL CYCLE 66 766 6.765e-23 1.749e-20
19 CELLULAR RESPONSE TO STRESS 97 1565 8.008e-23 1.961e-20
20 REGULATION OF ORGANELLE ORGANIZATION 82 1178 2.428e-22 5.649e-20
21 RESPONSE TO LIPID 70 888 4.71e-22 1.044e-19
22 REGULATION OF PROTEIN MODIFICATION PROCESS 100 1710 1.089e-21 2.304e-19
23 RESPONSE TO STEROID HORMONE 50 497 2.535e-20 5.128e-18
24 RESPONSE TO OXYGEN CONTAINING COMPOUND 86 1381 2.824e-20 5.476e-18
25 CELLULAR RESPONSE TO ENDOGENOUS STIMULUS 72 1008 3.184e-20 5.925e-18
26 CELL PROLIFERATION 57 672 1.683e-19 3.012e-17
27 REGULATION OF CELL DIFFERENTIATION 88 1492 3.167e-19 5.459e-17
28 POSITIVE REGULATION OF ORGANELLE ORGANIZATION 52 573 4.069e-19 6.762e-17
29 POSITIVE REGULATION OF DEVELOPMENTAL PROCESS 75 1142 5.901e-19 9.468e-17
30 POSITIVE REGULATION OF CELL PROLIFERATION 62 814 8.152e-19 1.264e-16
31 REGULATION OF PHOSPHORUS METABOLIC PROCESS 91 1618 1.526e-18 2.291e-16
32 CHROMOSOME ORGANIZATION 69 1009 2.257e-18 3.281e-16
33 REGULATION OF MITOTIC CELL CYCLE 46 468 2.333e-18 3.289e-16
34 POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS 86 1492 3.714e-18 5.082e-16
35 REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT 92 1672 3.936e-18 5.233e-16
36 NEGATIVE REGULATION OF CELL DEATH 63 872 5.716e-18 7.388e-16
37 POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 68 1004 6.83e-18 8.589e-16
38 CHROMATIN ORGANIZATION 54 663 1.002e-17 1.227e-15
39 CELLULAR RESPONSE TO DNA DAMAGE STIMULUS 56 720 1.88e-17 2.243e-15
40 CHROMATIN MODIFICATION 48 539 2.246e-17 2.549e-15
41 NEGATIVE REGULATION OF CELL CYCLE 43 433 2.192e-17 2.549e-15
42 POSITIVE REGULATION OF MOLECULAR FUNCTION 94 1791 3.428e-17 3.797e-15
43 RESPONSE TO ALCOHOL 39 362 4.611e-17 4.99e-15
44 CELL CYCLE PHASE TRANSITION 33 255 5.664e-17 5.99e-15
45 REGULATION OF CELL CYCLE PROCESS 48 558 8.947e-17 9.251e-15
46 CELL CYCLE CHECKPOINT 29 194 9.261e-17 9.368e-15
47 DNA METABOLIC PROCESS 56 758 1.852e-16 1.833e-14
48 PROTEIN PHOSPHORYLATION 63 944 2.69e-16 2.594e-14
49 NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 55 740 2.731e-16 2.594e-14
50 COVALENT CHROMATIN MODIFICATION 37 345 3.539e-16 3.293e-14
51 PHOSPHORYLATION 73 1228 4.134e-16 3.772e-14
52 POSITIVE REGULATION OF CELL DEATH 49 605 4.668e-16 4.177e-14
53 POSITIVE REGULATION OF CELL CYCLE 36 332 6.383e-16 5.604e-14
54 REPRODUCTION 75 1297 6.723e-16 5.793e-14
55 REGULATION OF CELLULAR RESPONSE TO STRESS 52 691 1.158e-15 9.796e-14
56 NEGATIVE REGULATION OF MITOTIC CELL CYCLE 28 199 1.58e-15 1.313e-13
57 REGULATION OF RESPONSE TO STRESS 80 1468 1.688e-15 1.378e-13
58 NEGATIVE REGULATION OF MOLECULAR FUNCTION 66 1079 3.426e-15 2.745e-13
59 RESPONSE TO ABIOTIC STIMULUS 64 1024 3.48e-15 2.745e-13
60 INTERSPECIES INTERACTION BETWEEN ORGANISMS 50 662 3.736e-15 2.85e-13
61 SYMBIOSIS ENCOMPASSING MUTUALISM THROUGH PARASITISM 50 662 3.736e-15 2.85e-13
62 NEGATIVE REGULATION OF BINDING 23 131 4.158e-15 3.12e-13
63 NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS 66 1087 4.888e-15 3.591e-13
64 GLAND DEVELOPMENT 38 395 4.939e-15 3.591e-13
65 POSITIVE REGULATION OF RESPONSE TO STIMULUS 93 1929 1.065e-14 7.626e-13
66 REGULATION OF PROTEIN BINDING 25 168 1.426e-14 1.005e-12
67 REGULATION OF TRANSFERASE ACTIVITY 60 946 1.489e-14 1.034e-12
68 MITOTIC CELL CYCLE CHECKPOINT 23 139 1.58e-14 1.081e-12
69 NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS 47 616 1.842e-14 1.242e-12
70 CELLULAR RESPONSE TO LIPID 40 457 2.18e-14 1.429e-12
71 NEGATIVE REGULATION OF CELL PROLIFERATION 48 643 2.169e-14 1.429e-12
72 POSITIVE REGULATION OF CELL DIFFERENTIATION 55 823 2.486e-14 1.607e-12
73 POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 75 1395 3.103e-14 1.978e-12
74 CELL DEVELOPMENT 76 1426 3.184e-14 2.002e-12
75 REGULATION OF CELLULAR LOCALIZATION 71 1277 3.29e-14 2.041e-12
76 POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS 66 1135 3.81e-14 2.332e-12
77 CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND 40 465 3.869e-14 2.338e-12
78 REGULATION OF DNA METABOLIC PROCESS 34 340 4.662e-14 2.777e-12
79 DNA INTEGRITY CHECKPOINT 23 146 4.715e-14 2.777e-12
80 POSITIVE REGULATION OF CELL COMMUNICATION 79 1532 5.22e-14 3.036e-12
81 AGING 30 264 5.293e-14 3.041e-12
82 ORGAN MORPHOGENESIS 55 841 6.077e-14 3.449e-12
83 NEUROGENESIS 74 1402 1.21e-13 6.782e-12
84 INTRACELLULAR SIGNAL TRANSDUCTION 79 1572 2.034e-13 1.127e-11
85 EMBRYO DEVELOPMENT 56 894 2.091e-13 1.145e-11
86 REGULATION OF APOPTOTIC SIGNALING PATHWAY 34 363 3.111e-13 1.683e-11
87 REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 81 1656 3.974e-13 2.113e-11
88 POSITIVE REGULATION OF CELL CYCLE PROCESS 28 247 3.997e-13 2.113e-11
89 NEGATIVE REGULATION OF CELL CYCLE PROCESS 26 214 5.585e-13 2.92e-11
90 CELLULAR RESPONSE TO STEROID HORMONE STIMULUS 26 218 8.628e-13 4.461e-11
91 NEGATIVE REGULATION OF PHOSPHORYLATION 36 422 9.966e-13 5.096e-11
92 REGULATION OF CELL CYCLE ARREST 19 108 1.008e-12 5.099e-11
93 REGULATION OF CHROMOSOME ORGANIZATION 29 278 1.256e-12 6.282e-11
94 CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND 51 799 1.372e-12 6.789e-11
95 RESPONSE TO NITROGEN COMPOUND 53 859 1.777e-12 8.704e-11
96 PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS 89 1977 2.262e-12 1.096e-10
97 CELLULAR RESPONSE TO HORMONE STIMULUS 41 552 2.295e-12 1.101e-10
98 MITOTIC DNA INTEGRITY CHECKPOINT 18 100 2.674e-12 1.269e-10
99 CELL DIVISION 37 460 2.782e-12 1.308e-10
100 ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY 46 689 4.087e-12 1.901e-10
101 NEGATIVE REGULATION OF PROTEIN BINDING 16 79 6.691e-12 3.082e-10
102 REGULATION OF MUSCLE CELL DIFFERENTIATION 21 152 8.259e-12 3.768e-10
103 REGULATION OF DNA BINDING 17 93 8.399e-12 3.794e-10
104 REGULATION OF CELL CYCLE PHASE TRANSITION 30 321 8.57e-12 3.834e-10
105 CENTRAL NERVOUS SYSTEM DEVELOPMENT 52 872 1.055e-11 4.676e-10
106 NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 45 684 1.169e-11 5.132e-10
107 NEGATIVE REGULATION OF RESPONSE TO STIMULUS 68 1360 1.654e-11 7.191e-10
108 REGULATION OF KINASE ACTIVITY 48 776 2.006e-11 8.525e-10
109 NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 39 541 2.015e-11 8.525e-10
110 NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 39 541 2.015e-11 8.525e-10
111 REGULATION OF CELL DIVISION 27 272 2.435e-11 1.021e-09
112 NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 55 983 2.948e-11 1.225e-09
113 RESPONSE TO GROWTH FACTOR 36 475 3.057e-11 1.249e-09
114 NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION 20 146 3.06e-11 1.249e-09
115 DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION 41 602 3.533e-11 1.429e-09
116 SKELETAL SYSTEM DEVELOPMENT 35 455 3.865e-11 1.528e-09
117 RESPONSE TO INORGANIC SUBSTANCE 36 479 3.875e-11 1.528e-09
118 RHYTHMIC PROCESS 28 298 3.815e-11 1.528e-09
119 POSITIVE REGULATION OF DNA METABOLIC PROCESS 22 185 5.376e-11 2.102e-09
120 POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 56 1036 7.178e-11 2.76e-09
121 POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 56 1036 7.178e-11 2.76e-09
122 TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 45 724 7.679e-11 2.929e-09
123 REGULATION OF PROTEIN LOCALIZATION 53 950 7.818e-11 2.957e-09
124 CELL CYCLE G2 M PHASE TRANSITION 19 138 8.768e-11 3.29e-09
125 REGULATION OF HOMEOSTATIC PROCESS 34 447 1.006e-10 3.746e-09
126 RESPONSE TO OXYGEN LEVELS 28 311 1.04e-10 3.839e-09
127 POSITIVE REGULATION OF CATALYTIC ACTIVITY 71 1518 1.135e-10 4.158e-09
128 REGULATION OF FIBROBLAST PROLIFERATION 15 81 1.183e-10 4.3e-09
129 RESPONSE TO EXTERNAL STIMULUS 80 1821 1.267e-10 4.571e-09
130 TUBE DEVELOPMENT 38 552 1.414e-10 5.062e-09
131 MITOTIC NUCLEAR DIVISION 30 361 1.582e-10 5.619e-09
132 RESPONSE TO DRUG 33 431 1.616e-10 5.696e-09
133 REPRODUCTIVE SYSTEM DEVELOPMENT 32 408 1.68e-10 5.879e-09
134 ORGAN REGENERATION 15 83 1.701e-10 5.906e-09
135 POSITIVE REGULATION OF CELL CYCLE ARREST 15 85 2.42e-10 8.341e-09
136 TUBE MORPHOGENESIS 28 323 2.5e-10 8.555e-09
137 REGULATION OF CELL DEVELOPMENT 48 836 2.563e-10 8.706e-09
138 POSITIVE REGULATION OF TRANSFERASE ACTIVITY 40 616 2.588e-10 8.726e-09
139 RESPONSE TO KETONE 21 182 2.615e-10 8.753e-09
140 PEPTIDYL SERINE MODIFICATION 19 148 2.997e-10 9.961e-09
141 EPITHELIUM DEVELOPMENT 51 945 5.878e-10 1.94e-08
142 NEGATIVE REGULATION OF CELL COMMUNICATION 59 1192 6.525e-10 2.138e-08
143 MULTI ORGANISM REPRODUCTIVE PROCESS 49 891 7.057e-10 2.296e-08
144 TISSUE MORPHOGENESIS 36 533 7.427e-10 2.383e-08
145 TISSUE DEVELOPMENT 69 1518 7.398e-10 2.383e-08
146 RESPONSE TO CORTICOSTEROID 20 176 9.201e-10 2.932e-08
147 CELL AGING 13 67 1.132e-09 3.583e-08
148 RESPONSE TO ESTROGEN 22 218 1.294e-09 4.068e-08
149 POSITIVE REGULATION OF BINDING 17 127 1.354e-09 4.229e-08
150 SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE 15 96 1.427e-09 4.426e-08
151 REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 33 470 1.485e-09 4.577e-08
152 REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY 18 145 1.535e-09 4.7e-08
153 REGULATION OF CELLULAR PROTEIN LOCALIZATION 36 552 1.901e-09 5.782e-08
154 NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION 15 98 1.918e-09 5.797e-08
155 DNA REPAIR 33 480 2.517e-09 7.557e-08
156 PEPTIDYL LYSINE MODIFICATION 26 312 2.565e-09 7.651e-08
157 POSITIVE REGULATION OF CHROMOSOME ORGANIZATION 18 150 2.668e-09 7.858e-08
158 CHROMATIN REMODELING 18 150 2.668e-09 7.858e-08
159 REGULATION OF TRANSPORT 76 1804 2.686e-09 7.86e-08
160 G1 DNA DAMAGE CHECKPOINT 13 73 3.435e-09 9.989e-08
161 POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY 19 171 3.551e-09 1.026e-07
162 REGULATION OF CATABOLIC PROCESS 42 731 3.607e-09 1.036e-07
163 CELL DEATH 51 1001 4.147e-09 1.184e-07
164 BONE DEVELOPMENT 18 156 5.028e-09 1.418e-07
165 MULTICELLULAR ORGANISM REPRODUCTION 43 768 5.006e-09 1.418e-07
166 ORGANELLE FISSION 33 496 5.673e-09 1.586e-07
167 PROTEIN COMPLEX SUBUNIT ORGANIZATION 67 1527 5.694e-09 1.586e-07
168 NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS 44 801 5.816e-09 1.611e-07
169 POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL 20 196 6.074e-09 1.672e-07
170 TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY 33 498 6.262e-09 1.714e-07
171 ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS 49 957 7.352e-09 2.001e-07
172 REGULATION OF NERVOUS SYSTEM DEVELOPMENT 42 750 7.607e-09 2.058e-07
173 REGENERATION 18 161 8.331e-09 2.241e-07
174 REGULATION OF NUCLEAR DIVISION 18 163 1.014e-08 2.692e-07
175 FOREBRAIN DEVELOPMENT 27 357 1.018e-08 2.692e-07
176 SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR 16 127 1.012e-08 2.692e-07
177 POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 46 876 1.027e-08 2.701e-07
178 POSITIVE REGULATION OF FIBROBLAST PROLIFERATION 11 53 1.035e-08 2.706e-07
179 RESPONSE TO WOUNDING 35 563 1.099e-08 2.857e-07
180 RESPONSE TO ESTRADIOL 17 146 1.172e-08 3.03e-07
181 POSITIVE REGULATION OF DNA BINDING 10 42 1.183e-08 3.042e-07
182 EMBRYONIC MORPHOGENESIS 34 539 1.254e-08 3.207e-07
183 REGULATION OF INTRACELLULAR TRANSPORT 37 621 1.263e-08 3.212e-07
184 REGULATION OF CELL CYCLE G1 S PHASE TRANSITION 17 147 1.301e-08 3.289e-07
185 NEGATIVE REGULATION OF ORGANELLE ORGANIZATION 28 387 1.416e-08 3.562e-07
186 HEAD DEVELOPMENT 40 709 1.444e-08 3.612e-07
187 POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION 18 167 1.489e-08 3.704e-07
188 BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE 16 131 1.589e-08 3.933e-07
189 REGULATION OF GENE EXPRESSION EPIGENETIC 21 229 1.702e-08 4.19e-07
190 RESPONSE TO EXTRACELLULAR STIMULUS 30 441 1.739e-08 4.258e-07
191 RNA PROCESSING 44 835 1.991e-08 4.851e-07
192 POSITIVE REGULATION OF INTRACELLULAR TRANSPORT 27 370 2.16e-08 5.208e-07
193 REGULATION OF CHROMATIN ORGANIZATION 17 152 2.157e-08 5.208e-07
194 RESPONSE TO NUTRIENT 19 191 2.215e-08 5.312e-07
195 REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION 13 85 2.343e-08 5.59e-07
196 PROTEIN AUTOPHOSPHORYLATION 19 192 2.411e-08 5.725e-07
197 HISTONE PHOSPHORYLATION 8 25 2.748e-08 6.49e-07
198 POSITIVE REGULATION OF TRANSPORT 47 936 2.779e-08 6.531e-07
199 NEGATIVE REGULATION OF TRANSFERASE ACTIVITY 26 351 2.929e-08 6.848e-07
200 REGULATION OF MITOCHONDRION ORGANIZATION 20 218 3.712e-08 8.635e-07
201 POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY 9 36 4.07e-08 9.422e-07
202 REGULATION OF ORGAN MORPHOGENESIS 21 242 4.455e-08 1.026e-06
203 ENDOCRINE SYSTEM DEVELOPMENT 15 123 4.571e-08 1.048e-06
204 POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION 32 514 4.638e-08 1.058e-06
205 POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION 26 360 4.875e-08 1.107e-06
206 APOPTOTIC SIGNALING PATHWAY 23 289 5.071e-08 1.145e-06
207 NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 29 437 5.185e-08 1.166e-06
208 CELLULAR RESPONSE TO OXYGEN LEVELS 16 143 5.583e-08 1.243e-06
209 REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR 17 162 5.584e-08 1.243e-06
210 REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS 49 1021 5.624e-08 1.246e-06
211 REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS 16 145 6.795e-08 1.499e-06
212 IMMUNE SYSTEM DEVELOPMENT 34 582 8.099e-08 1.778e-06
213 REGULATION OF PROTEIN ACETYLATION 11 64 8.211e-08 1.794e-06
214 CELL CYCLE G1 S PHASE TRANSITION 14 111 8.381e-08 1.814e-06
215 G1 S TRANSITION OF MITOTIC CELL CYCLE 14 111 8.381e-08 1.814e-06
216 MACROMOLECULAR COMPLEX ASSEMBLY 60 1398 8.774e-08 1.873e-06
217 REGULATION OF REPRODUCTIVE PROCESS 15 129 8.697e-08 1.873e-06
218 MORPHOGENESIS OF A BRANCHING STRUCTURE 17 167 8.742e-08 1.873e-06
219 REGULATION OF CYTOSKELETON ORGANIZATION 31 502 9.085e-08 1.93e-06
220 SEXUAL REPRODUCTION 39 730 9.371e-08 1.982e-06
221 REGULATION OF CELL PROJECTION ORGANIZATION 33 558 9.523e-08 2.005e-06
222 POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY 10 52 1.055e-07 2.212e-06
223 MORPHOGENESIS OF AN EPITHELIUM 27 400 1.073e-07 2.239e-06
224 MOVEMENT OF CELL OR SUBCELLULAR COMPONENT 56 1275 1.173e-07 2.438e-06
225 POSITIVE REGULATION OF CELL DIVISION 15 132 1.183e-07 2.446e-06
226 RESPONSE TO REACTIVE OXYGEN SPECIES 18 191 1.193e-07 2.455e-06
227 REGULATION OF CELLULAR COMPONENT BIOGENESIS 40 767 1.205e-07 2.471e-06
228 RESPONSE TO OXIDATIVE STRESS 25 352 1.222e-07 2.494e-06
229 CELLULAR RESPONSE TO ALCOHOL 14 115 1.315e-07 2.672e-06
230 MACROMOLECULE DEACYLATION 11 67 1.341e-07 2.713e-06
231 REGULATION OF CANONICAL WNT SIGNALING PATHWAY 20 236 1.378e-07 2.777e-06
232 POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS 27 406 1.449e-07 2.894e-06
233 EMBRYONIC ORGAN DEVELOPMENT 27 406 1.449e-07 2.894e-06
234 POSITIVE REGULATION OF HOMEOSTATIC PROCESS 19 216 1.586e-07 3.153e-06
235 POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION 12 84 1.77e-07 3.504e-06
236 RESPONSE TO RADIATION 27 413 2.041e-07 4.023e-06
237 REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY 9 43 2.141e-07 4.204e-06
238 NEGATIVE REGULATION OF CELL DIFFERENTIATION 34 609 2.356e-07 4.607e-06
239 CARDIOVASCULAR SYSTEM DEVELOPMENT 40 788 2.443e-07 4.736e-06
240 CIRCULATORY SYSTEM DEVELOPMENT 40 788 2.443e-07 4.736e-06
241 EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING 32 554 2.545e-07 4.914e-06
242 POSITIVE REGULATION OF CELL DEVELOPMENT 29 472 2.656e-07 5.107e-06
243 REGULATION OF PROTEIN CATABOLIC PROCESS 26 393 2.738e-07 5.242e-06
244 REGULATION OF DNA REPLICATION 16 161 2.919e-07 5.567e-06
245 RESPONSE TO ACID CHEMICAL 23 319 3.013e-07 5.722e-06
246 POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION 28 448 3.037e-07 5.744e-06
247 POSITIVE REGULATION OF MITOTIC CELL CYCLE 14 123 3.063e-07 5.77e-06
248 CELLULAR RESPONSE TO NITROGEN COMPOUND 30 505 3.377e-07 6.336e-06
249 NEGATIVE REGULATION OF CATALYTIC ACTIVITY 41 829 3.401e-07 6.356e-06
250 REGULATION OF BODY FLUID LEVELS 30 506 3.522e-07 6.555e-06
251 CELLULAR RESPONSE TO OXIDATIVE STRESS 17 184 3.557e-07 6.594e-06
252 OSSIFICATION 20 251 3.731e-07 6.889e-06
253 UROGENITAL SYSTEM DEVELOPMENT 22 299 3.867e-07 7.112e-06
254 GAMETE GENERATION 33 595 4.139e-07 7.582e-06
255 SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION 26 404 4.651e-07 8.486e-06
256 REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION 14 128 5.02e-07 9.124e-06
257 REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL 21 280 5.205e-07 9.423e-06
258 DIGESTIVE SYSTEM DEVELOPMENT 15 148 5.323e-07 9.601e-06
259 ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS 11 77 5.78e-07 1.038e-05
260 RESPONSE TO AMINE 9 48 5.805e-07 1.039e-05
261 REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING 8 36 6.282e-07 1.12e-05
262 SENSORY ORGAN DEVELOPMENT 29 493 6.513e-07 1.157e-05
263 MUSCLE CELL DIFFERENTIATION 19 237 6.658e-07 1.178e-05
264 EPITHELIAL CELL DIFFERENTIATION 29 495 7.073e-07 1.247e-05
265 INTRINSIC APOPTOTIC SIGNALING PATHWAY 15 152 7.508e-07 1.312e-05
266 MRNA METABOLIC PROCESS 33 611 7.485e-07 1.312e-05
267 BONE MORPHOGENESIS 11 79 7.53e-07 1.312e-05
268 POSITIVE REGULATION OF PROTEOLYSIS 24 363 8.009e-07 1.39e-05
269 PROTEIN SUMOYLATION 13 115 8.779e-07 1.518e-05
270 POSITIVE REGULATION OF PROTEIN COMPLEX ASSEMBLY 17 197 9.328e-07 1.608e-05
271 DNA GEOMETRIC CHANGE 11 81 9.73e-07 1.671e-05
272 REGULATION OF PROTEIN STABILITY 18 221 1.042e-06 1.776e-05
273 REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE 7 27 1.041e-06 1.776e-05
274 NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY 17 200 1.152e-06 1.955e-05
275 CYTOSKELETON ORGANIZATION 40 838 1.167e-06 1.974e-05
276 SKELETAL SYSTEM MORPHOGENESIS 17 201 1.234e-06 2.081e-05
277 REGULATION OF CYTOPLASMIC TRANSPORT 28 481 1.251e-06 2.102e-05
278 CELL ACTIVATION 31 568 1.316e-06 2.202e-05
279 NEURON DIFFERENTIATION 41 874 1.322e-06 2.205e-05
280 REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE 9 53 1.398e-06 2.319e-05
281 DNA CONFORMATION CHANGE 20 273 1.401e-06 2.319e-05
282 REGULATION OF MAPK CASCADE 34 660 1.467e-06 2.421e-05
283 RESPONSE TO PEPTIDE 25 404 1.581e-06 2.6e-05
284 REGULATION OF GROWTH 33 633 1.626e-06 2.664e-05
285 MITOTIC SPINDLE ORGANIZATION 10 69 1.652e-06 2.697e-05
286 PLATELET ACTIVATION 14 142 1.775e-06 2.887e-05
287 TISSUE REMODELING 11 87 2.008e-06 3.256e-05
288 ODONTOGENESIS 12 105 2.058e-06 3.324e-05
289 INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY 10 71 2.161e-06 3.479e-05
290 REGULATION OF STEM CELL PROLIFERATION 11 88 2.253e-06 3.614e-05
291 EPITHELIAL TO MESENCHYMAL TRANSITION 9 56 2.261e-06 3.616e-05
292 POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT 20 282 2.309e-06 3.654e-05
293 REGULATION OF NEURON DIFFERENTIATION 30 554 2.293e-06 3.654e-05
294 MACROMOLECULE CATABOLIC PROCESS 42 926 2.303e-06 3.654e-05
295 RESPONSE TO UV 13 126 2.492e-06 3.93e-05
296 HEART MORPHOGENESIS 17 212 2.568e-06 4.037e-05
297 TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 16 190 2.683e-06 4.203e-05
298 PROTEIN COMPLEX BIOGENESIS 48 1132 2.743e-06 4.269e-05
299 PROTEIN COMPLEX ASSEMBLY 48 1132 2.743e-06 4.269e-05
300 REGULATION OF SUPEROXIDE ANION GENERATION 5 12 2.765e-06 4.274e-05
301 REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS 5 12 2.765e-06 4.274e-05
302 HEMOSTASIS 21 311 2.818e-06 4.342e-05
303 REGULATION OF PROTEOLYSIS 35 711 2.847e-06 4.371e-05
304 APPENDAGE DEVELOPMENT 15 169 2.87e-06 4.379e-05
305 LIMB DEVELOPMENT 15 169 2.87e-06 4.379e-05
306 CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS 9 58 3.063e-06 4.644e-05
307 RESPONSE TO HYDROGEN PEROXIDE 12 109 3.064e-06 4.644e-05
308 CELLULAR RESPONSE TO ABIOTIC STIMULUS 19 263 3.153e-06 4.764e-05
309 REGULATION OF CYTOKINE PRODUCTION 30 563 3.169e-06 4.769e-05
310 REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA 8 44 3.177e-06 4.769e-05
311 SENSORY ORGAN MORPHOGENESIS 18 239 3.194e-06 4.779e-05
312 INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS 7 32 3.606e-06 5.378e-05
313 SEX DIFFERENTIATION 19 266 3.722e-06 5.533e-05
314 LEUKOCYTE DIFFERENTIATION 20 292 3.92e-06 5.809e-05
315 REGULATION OF MICROTUBULE BASED PROCESS 18 243 4.034e-06 5.959e-05
316 CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 28 513 4.321e-06 6.362e-05
317 OVULATION CYCLE 12 113 4.482e-06 6.577e-05
318 G2 DNA DAMAGE CHECKPOINT 7 33 4.495e-06 6.577e-05
319 RELEASE OF CYTOCHROME C FROM MITOCHONDRIA 6 22 4.579e-06 6.659e-05
320 HISTONE H3 DEACETYLATION 6 22 4.579e-06 6.659e-05
321 POSITIVE REGULATION OF STEM CELL PROLIFERATION 9 61 4.719e-06 6.841e-05
322 NEGATIVE REGULATION OF TRANSPORT 26 458 4.746e-06 6.858e-05
323 REGULATION OF PROTEIN COMPLEX ASSEMBLY 23 375 4.801e-06 6.917e-05
324 PROTEASOMAL PROTEIN CATABOLIC PROCESS 19 271 4.879e-06 7.007e-05
325 MUSCLE STRUCTURE DEVELOPMENT 25 432 5.185e-06 7.423e-05
326 RESPONSE TO ETHANOL 13 136 5.845e-06 8.342e-05
327 FEMALE SEX DIFFERENTIATION 12 116 5.896e-06 8.389e-05
328 REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY 11 97 5.915e-06 8.391e-05
329 NEGATIVE REGULATION OF KINASE ACTIVITY 18 250 5.994e-06 8.477e-05
330 REGULATION OF SUPEROXIDE METABOLIC PROCESS 6 23 6.087e-06 8.582e-05
331 HORMONE MEDIATED SIGNALING PATHWAY 14 158 6.26e-06 8.781e-05
332 REGULATION OF CELLULAR AMIDE METABOLIC PROCESS 22 354 6.265e-06 8.781e-05
333 REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT 8 48 6.288e-06 8.786e-05
334 POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 25 437 6.332e-06 8.802e-05
335 CELLULAR RESPONSE TO RADIATION 13 137 6.337e-06 8.802e-05
336 MAMMARY GLAND DEVELOPMENT 12 117 6.447e-06 8.928e-05
337 RESPONSE TO VITAMIN 11 98 6.539e-06 9.029e-05
338 CELLULAR COMPONENT MORPHOGENESIS 40 900 6.592e-06 9.075e-05
339 POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION 20 303 6.82e-06 9.361e-05
340 PROTEIN LOCALIZATION TO ORGANELLE 29 556 6.99e-06 9.566e-05
341 WOUND HEALING 26 470 7.523e-06 0.0001026
342 RESPONSE TO LIGHT STIMULUS 19 280 7.805e-06 0.0001062
343 LOCOMOTION 46 1114 8.947e-06 0.0001214
344 RESPONSE TO FATTY ACID 10 83 9.105e-06 0.0001232
345 REGULATION OF WNT SIGNALING PATHWAY 20 310 9.558e-06 0.0001289
346 NEGATIVE REGULATION OF CYTOKINE PRODUCTION 16 211 1.029e-05 0.0001383
347 REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS 9 67 1.042e-05 0.0001397
348 EPHRIN RECEPTOR SIGNALING PATHWAY 10 85 1.129e-05 0.0001505
349 POSITIVE REGULATION OF CHROMATIN MODIFICATION 10 85 1.129e-05 0.0001505
350 CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES 11 104 1.164e-05 0.0001547
351 POSITIVE REGULATION OF KINASE ACTIVITY 26 482 1.171e-05 0.0001552
352 NEGATIVE REGULATION OF HOMEOSTATIC PROCESS 12 124 1.174e-05 0.0001552
353 RESPONSE TO IONIZING RADIATION 13 145 1.178e-05 0.0001553
354 POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS 18 263 1.202e-05 0.0001576
355 STEM CELL DIFFERENTIATION 15 190 1.2e-05 0.0001576
356 REGULATION OF DOUBLE STRAND BREAK REPAIR 7 38 1.213e-05 0.0001586
357 POSITIVE REGULATION OF DNA REPLICATION 10 86 1.254e-05 0.0001634
358 INTRACELLULAR RECEPTOR SIGNALING PATHWAY 14 168 1.268e-05 0.0001649
359 STEROID HORMONE MEDIATED SIGNALING PATHWAY 12 125 1.275e-05 0.0001652
360 DNA RECOMBINATION 16 215 1.302e-05 0.0001683
361 MALE GAMETE GENERATION 26 486 1.352e-05 0.0001743
362 POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS 15 192 1.36e-05 0.0001748
363 REGULATION OF MAP KINASE ACTIVITY 20 319 1.452e-05 0.0001861
364 RNA SPLICING VIA TRANSESTERIFICATION REACTIONS 18 267 1.475e-05 0.0001885
365 REGULATION OF MEMBRANE PERMEABILITY 9 70 1.499e-05 0.0001911
366 MRNA PROCESSING 24 432 1.574e-05 0.0002001
367 REGULATION OF CELLULAR COMPONENT MOVEMENT 35 771 1.637e-05 0.0002076
368 NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION 8 55 1.785e-05 0.0002251
369 REGULATION OF KIDNEY DEVELOPMENT 8 55 1.785e-05 0.0002251
370 WNT SIGNALING PATHWAY 21 351 1.801e-05 0.0002264
371 POSITIVE REGULATION OF LIGASE ACTIVITY 11 110 1.988e-05 0.0002493
372 GROWTH 23 410 2.028e-05 0.0002536
373 CELLULAR RESPONSE TO ESTROGEN STIMULUS 7 41 2.047e-05 0.0002547
374 PROSTATE GLAND DEVELOPMENT 7 41 2.047e-05 0.0002547
375 POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA 6 28 2.079e-05 0.0002579
376 CELL CYCLE ARREST 13 154 2.249e-05 0.0002783
377 APOPTOTIC MITOCHONDRIAL CHANGES 8 57 2.336e-05 0.0002883
378 NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC 11 112 2.357e-05 0.0002894
379 EAR MORPHOGENESIS 11 112 2.357e-05 0.0002894
380 PITUITARY GLAND DEVELOPMENT 7 42 2.413e-05 0.0002954
381 NCRNA METABOLIC PROCESS 27 533 2.429e-05 0.0002959
382 REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION 14 178 2.435e-05 0.0002959
383 REGULATION OF OSSIFICATION 14 178 2.435e-05 0.0002959
384 REGULATION OF PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY 6 29 2.575e-05 0.0003096
385 POSITIVE REGULATION OF PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY 6 29 2.575e-05 0.0003096
386 MESENCHYMAL CELL DIFFERENTIATION 12 134 2.575e-05 0.0003096
387 POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT 6 29 2.575e-05 0.0003096
388 REGULATION OF DNA REPAIR 9 75 2.64e-05 0.0003158
389 ODONTOGENESIS OF DENTIN CONTAINING TOOTH 9 75 2.64e-05 0.0003158
390 RESPONSE TO METAL ION 20 333 2.692e-05 0.0003204
391 DEVELOPMENTAL GROWTH 20 333 2.692e-05 0.0003204
392 PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION 16 229 2.837e-05 0.0003367
393 POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS 8 59 3.022e-05 0.0003569
394 REGULATION OF CELL CYCLE G2 M PHASE TRANSITION 8 59 3.022e-05 0.0003569
395 RESPONSE TO AMPHETAMINE 6 30 3.162e-05 0.0003715
396 CELLULAR RESPONSE TO ESTRADIOL STIMULUS 6 30 3.162e-05 0.0003715
397 DIENCEPHALON DEVELOPMENT 9 77 3.268e-05 0.000383
398 NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION 10 96 3.316e-05 0.0003877
399 IN UTERO EMBRYONIC DEVELOPMENT 19 311 3.382e-05 0.0003944
400 RNA SPLICING 21 367 3.473e-05 0.000404
401 REGULATION OF EPITHELIAL CELL PROLIFERATION 18 285 3.516e-05 0.0004079
402 NEURON PROJECTION DEVELOPMENT 27 545 3.572e-05 0.0004135
403 REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION 5 19 3.595e-05 0.0004151
404 CELL MOTILITY 36 835 3.677e-05 0.0004225
405 LOCALIZATION OF CELL 36 835 3.677e-05 0.0004225
406 LYMPHOCYTE DIFFERENTIATION 15 209 3.686e-05 0.0004225
407 CELLULAR RESPONSE TO HYDROGEN PEROXIDE 8 61 3.87e-05 0.0004424
408 PROTEIN LOCALIZATION 63 1805 3.89e-05 0.0004436
409 PROTEIN CATABOLIC PROCESS 28 579 3.927e-05 0.0004468
410 PEPTIDYL TYROSINE MODIFICATION 14 186 3.965e-05 0.00045
411 REGULATION OF HYDROLASE ACTIVITY 50 1327 4.076e-05 0.0004614
412 PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL 37 873 4.105e-05 0.0004636
413 POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY 11 119 4.156e-05 0.0004682
414 CARDIAC VENTRICLE MORPHOGENESIS 8 62 4.363e-05 0.0004891
415 POSITIVE REGULATION OF NUCLEAR DIVISION 8 62 4.363e-05 0.0004891
416 RESPONSE TO COCAINE 7 46 4.454e-05 0.0004958
417 NEGATIVE REGULATION OF DNA BINDING 7 46 4.454e-05 0.0004958
418 NEURON PROJECTION MORPHOGENESIS 22 402 4.441e-05 0.0004958
419 CELLULAR RESPONSE TO EXTERNAL STIMULUS 17 264 4.533e-05 0.0005022
420 ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE 17 264 4.533e-05 0.0005022
421 MICROTUBULE BASED PROCESS 26 522 4.554e-05 0.0005033
422 MULTI MULTICELLULAR ORGANISM PROCESS 15 213 4.586e-05 0.0005057
423 GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR 6 32 4.658e-05 0.0005124
424 MYELOID CELL DIFFERENTIATION 14 189 4.726e-05 0.0005186
425 MICROTUBULE CYTOSKELETON ORGANIZATION 20 348 5.004e-05 0.0005478
426 SECRETION 28 588 5.14e-05 0.0005614
427 RESPONSE TO TRANSFORMING GROWTH FACTOR BETA 12 144 5.25e-05 0.0005721
428 HEART DEVELOPMENT 24 466 5.299e-05 0.0005761
429 DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS 15 216 5.383e-05 0.0005838
430 REGULATION OF CYTOKINESIS 8 64 5.507e-05 0.0005945
431 POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS 8 64 5.507e-05 0.0005945
432 REGULATION OF NEURON PROJECTION DEVELOPMENT 22 408 5.532e-05 0.0005958
433 VIRAL LATENCY 4 11 5.576e-05 0.0005992
434 REGULATION OF CELL AGING 6 33 5.593e-05 0.0005997
435 REGULATION OF MUSCLE TISSUE DEVELOPMENT 10 103 6.091e-05 0.0006486
436 REGULATION OF MUSCLE ORGAN DEVELOPMENT 10 103 6.091e-05 0.0006486
437 BONE RESORPTION 5 21 6.078e-05 0.0006486
438 REGULATION OF METAL ION TRANSPORT 19 325 6.125e-05 0.0006506
439 CARDIAC CHAMBER MORPHOGENESIS 10 104 6.616e-05 0.0006999
440 REGULATION OF RESPONSE TO WOUNDING 22 413 6.618e-05 0.0006999
441 EAR DEVELOPMENT 14 195 6.638e-05 0.0007003
442 TISSUE HOMEOSTASIS 13 171 6.717e-05 0.0007071
443 RESPONSE TO TRANSITION METAL NANOPARTICLE 12 148 6.856e-05 0.0007201
444 CELLULAR RESPONSE TO UV 8 66 6.89e-05 0.000722
445 NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 11 126 7.028e-05 0.0007348
446 REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS 17 274 7.191e-05 0.0007502
447 POSITIVE REGULATION OF PROTEIN OLIGOMERIZATION 5 22 7.731e-05 0.000798
448 ENDOCARDIAL CUSHION MORPHOGENESIS 5 22 7.731e-05 0.000798
449 REGULATION OF SECRETION 31 699 7.728e-05 0.000798
450 RESPONSE TO PROGESTERONE 7 50 7.735e-05 0.000798
451 RESPONSE TO GAMMA RADIATION 7 50 7.735e-05 0.000798
452 REGULATION OF PROTEIN OLIGOMERIZATION 6 35 7.912e-05 0.0008091
453 BONE REMODELING 6 35 7.912e-05 0.0008091
454 RESPONSE TO MINERALOCORTICOID 6 35 7.912e-05 0.0008091
455 PATTERN SPECIFICATION PROCESS 22 418 7.891e-05 0.0008091
456 HEPATICOBILIARY SYSTEM DEVELOPMENT 11 128 8.109e-05 0.0008275
457 REGULATION OF IMMUNE SYSTEM PROCESS 51 1403 8.48e-05 0.0008634
458 CELLULAR RESPONSE TO ACID CHEMICAL 13 175 8.507e-05 0.0008643
459 POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION 8 68 8.55e-05 0.0008667
460 CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM 16 252 8.911e-05 0.0009013
461 EMBRYONIC ORGAN MORPHOGENESIS 17 279 8.975e-05 0.0009059
462 REGULATION OF LIGASE ACTIVITY 11 130 9.33e-05 0.0009356
463 POSITIVE REGULATION OF PROTEIN ACETYLATION 6 36 9.328e-05 0.0009356
464 POSITIVE REGULATION OF ERBB SIGNALING PATHWAY 6 36 9.328e-05 0.0009356
465 REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 12 153 9.445e-05 0.0009451
466 CHROMATIN ASSEMBLY OR DISASSEMBLY 13 177 9.548e-05 0.0009533
467 CELLULAR COMPONENT DISASSEMBLY 25 515 9.573e-05 0.0009538
468 REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 20 365 9.637e-05 0.0009582
469 REGULATION OF NUCLEASE ACTIVITY 5 23 9.709e-05 0.0009592
470 LEUKOCYTE APOPTOTIC PROCESS 5 23 9.709e-05 0.0009592
471 PROTEIN INSERTION INTO MEMBRANE 5 23 9.709e-05 0.0009592
472 POSITIVE REGULATION OF CATABOLIC PROCESS 21 395 9.927e-05 0.0009786
473 POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION 7 52 9.994e-05 0.0009831
474 IMMUNE SYSTEM PROCESS 66 1984 0.0001056 0.001037
475 REGIONALIZATION 18 311 0.000108 0.001058
476 REGULATION OF RECEPTOR INTERNALIZATION 6 37 0.0001094 0.001069
477 MESONEPHROS DEVELOPMENT 9 90 0.0001126 0.001099
478 MACROMOLECULE METHYLATION 14 205 0.0001134 0.001104
479 POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS 10 111 0.0001147 0.00111
480 COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION 10 111 0.0001147 0.00111
481 NEGATIVE REGULATION OF DNA METABOLIC PROCESS 10 111 0.0001147 0.00111
482 REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE 4 13 0.0001169 0.001119
483 MITOTIC G2 DNA DAMAGE CHECKPOINT 4 13 0.0001169 0.001119
484 POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE 4 13 0.0001169 0.001119
485 VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT 4 13 0.0001169 0.001119
486 ANATOMICAL STRUCTURE HOMEOSTASIS 17 285 0.0001162 0.001119
487 PROTEIN UBIQUITINATION INVOLVED IN UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS 11 134 0.0001225 0.00117
488 REGULATION OF OSTEOBLAST DIFFERENTIATION 10 112 0.0001237 0.001179
489 NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS 20 372 0.0001245 0.001185
490 REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 14 207 0.0001256 0.001193
491 RESPONSE TO TESTOSTERONE 6 38 0.0001276 0.001207
492 MESENCHYME MORPHOGENESIS 6 38 0.0001276 0.001207
493 MITOCHONDRIAL MEMBRANE ORGANIZATION 9 92 0.0001336 0.001261
494 CATABOLIC PROCESS 60 1773 0.0001432 0.001348
495 NEGATIVE REGULATION OF DNA REPLICATION 7 55 0.0001436 0.00135
496 NEGATIVE REGULATION OF ENDOCYTOSIS 6 39 0.0001482 0.001385
497 BASE EXCISION REPAIR 6 39 0.0001482 0.001385
498 POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION 5 25 0.0001481 0.001385
499 RESPONSE TO ALKALOID 11 137 0.0001492 0.001391
500 VASCULATURE DEVELOPMENT 23 469 0.0001562 0.001454
501 SMAD PROTEIN SIGNAL TRANSDUCTION 7 56 0.0001612 0.001477
502 REGULATION OF HISTONE METHYLATION 7 56 0.0001612 0.001477
503 SPECIFICATION OF ORGAN IDENTITY 4 14 0.0001609 0.001477
504 POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING 4 14 0.0001609 0.001477
505 MULTI ORGANISM METABOLIC PROCESS 11 138 0.0001591 0.001477
506 POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT 7 56 0.0001612 0.001477
507 OUTFLOW TRACT MORPHOGENESIS 7 56 0.0001612 0.001477
508 PEPTIDYL ARGININE METHYLATION 4 14 0.0001609 0.001477
509 MEMBRANE ORGANIZATION 36 899 0.000162 0.001478
510 ANGIOGENESIS 17 293 0.000162 0.001478
511 POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 12 162 0.0001625 0.00148
512 NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL 11 139 0.0001696 0.001541
513 PROTEIN METHYLATION 10 117 0.0001777 0.001609
514 PROTEIN ALKYLATION 10 117 0.0001777 0.001609
515 NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION 5 26 0.0001802 0.001628
516 MYELOID LEUKOCYTE DIFFERENTIATION 9 96 0.0001852 0.00167
517 REGULATION OF SYSTEM PROCESS 24 507 0.0001919 0.001727
518 ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY 11 141 0.0001924 0.001728
519 EYE DEVELOPMENT 18 326 0.0001941 0.00174
520 POSITIVE REGULATION OF KIDNEY DEVELOPMENT 6 41 0.0001971 0.001761
521 ANDROGEN RECEPTOR SIGNALING PATHWAY 6 41 0.0001971 0.001761
522 GLAND MORPHOGENESIS 9 97 0.0002004 0.001787
523 NCRNA PROCESSING 20 386 0.0002034 0.00181
524 REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY 4 15 0.0002158 0.001898
525 OTIC VESICLE DEVELOPMENT 4 15 0.0002158 0.001898
526 POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY 4 15 0.0002158 0.001898
527 HISTONE H2A ACETYLATION 4 15 0.0002158 0.001898
528 POSITIVE REGULATION OF NUCLEASE ACTIVITY 4 15 0.0002158 0.001898
529 ACTIVATION OF ANAPHASE PROMOTING COMPLEX ACTIVITY 4 15 0.0002158 0.001898
530 POSITIVE REGULATION OF HEART GROWTH 5 27 0.0002174 0.001909
531 REGULATION OF DENDRITE DEVELOPMENT 10 120 0.0002188 0.001917
532 ACTIN FILAMENT BASED PROCESS 22 450 0.0002257 0.001963
533 POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS 6 42 0.000226 0.001963
534 REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS 8 78 0.0002261 0.001963
535 DNA METHYLATION OR DEMETHYLATION 7 59 0.0002247 0.001963
536 REGULATION OF HEART GROWTH 6 42 0.000226 0.001963
537 NEGATIVE REGULATION OF DEFENSE RESPONSE 11 144 0.0002313 0.002004
538 CELLULAR RESPONSE TO PEPTIDE 16 274 0.0002332 0.002016
539 ANTERIOR POSTERIOR PATTERN SPECIFICATION 13 194 0.000238 0.00205
540 DNA PACKAGING 13 194 0.000238 0.00205
541 NEGATIVE REGULATION OF MAPK CASCADE 11 145 0.0002457 0.002113
542 DNA MODIFICATION 8 79 0.000247 0.002121
543 NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION 14 221 0.0002483 0.002128
544 EMBRYONIC SKELETAL SYSTEM DEVELOPMENT 10 122 0.0002504 0.002133
545 REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION 7 60 0.0002499 0.002133
546 REGULATION OF MUSCLE SYSTEM PROCESS 13 195 0.0002502 0.002133
547 POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 9 100 0.0002525 0.002144
548 LIMBIC SYSTEM DEVELOPMENT 9 100 0.0002525 0.002144
549 PROTEIN PEPTIDYL PROLYL ISOMERIZATION 6 43 0.000258 0.002187
550 REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR 5 28 0.0002602 0.002197
551 MAMMARY GLAND DUCT MORPHOGENESIS 5 28 0.0002602 0.002197
552 BLOOD VESSEL MORPHOGENESIS 19 364 0.0002658 0.002241
553 POSITIVE REGULATION OF NEURON DIFFERENTIATION 17 306 0.0002702 0.002273
554 CARTILAGE DEVELOPMENT 11 147 0.0002767 0.002324
555 DNA LIGATION 4 16 0.000283 0.002368
556 MITOCHONDRIAL ELECTRON TRANSPORT CYTOCHROME C TO OXYGEN 4 16 0.000283 0.002368
557 RIBOSOME BIOGENESIS 17 308 0.0002914 0.002435
558 MALE SEX DIFFERENTIATION 11 148 0.0002934 0.002447
559 NEURON DEVELOPMENT 29 687 0.0003005 0.002501
560 KIDNEY EPITHELIUM DEVELOPMENT 10 125 0.0003048 0.002533
561 REGULATION OF TISSUE REMODELING 7 62 0.000307 0.002546
562 REGULATION OF HEART MORPHOGENESIS 5 29 0.000309 0.002554
563 EMBRYONIC HINDLIMB MORPHOGENESIS 5 29 0.000309 0.002554
564 REGULATION OF CIRCADIAN RHYTHM 9 103 0.0003153 0.002597
565 REGULATION OF CALCIUM ION IMPORT 9 103 0.0003153 0.002597
566 DNA METHYLATION 6 45 0.0003328 0.002726
567 ENDOCHONDRAL BONE MORPHOGENESIS 6 45 0.0003328 0.002726
568 DNA ALKYLATION 6 45 0.0003328 0.002726
569 REGULATION OF ION TRANSPORT 26 592 0.0003379 0.002763
570 TAXIS 22 464 0.0003443 0.002811
571 EMBRYONIC PLACENTA DEVELOPMENT 8 83 0.0003474 0.002826
572 LYMPHOCYTE ACTIVATION 18 342 0.0003469 0.002826
573 HOMEOSTATIC PROCESS 47 1337 0.0003487 0.002832
574 NUCLEOSOME DISASSEMBLY 4 17 0.000364 0.002939
575 PROTEIN DNA COMPLEX DISASSEMBLY 4 17 0.000364 0.002939
576 CHROMATIN DISASSEMBLY 4 17 0.000364 0.002939
577 RESPONSE TO X RAY 5 30 0.0003645 0.002939
578 POSITIVE REGULATION OF WNT SIGNALING PATHWAY 11 152 0.000369 0.002971
579 PEPTIDYL THREONINE MODIFICATION 6 46 0.000376 0.003022
580 HISTONE METHYLATION 8 84 0.000377 0.003025
581 CARDIAC VENTRICLE DEVELOPMENT 9 106 0.0003905 0.003128
582 PROTEIN LOCALIZATION TO MEMBRANE 19 376 0.0003979 0.003181
583 CELLULAR MACROMOLECULE LOCALIZATION 44 1234 0.0004028 0.003215
584 POSITIVE REGULATION OF MAPK CASCADE 22 470 0.00041 0.003267
585 CELL PART MORPHOGENESIS 27 633 0.0004114 0.003272
586 POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 11 154 0.0004126 0.003276
587 REGULATION OF SEQUESTERING OF CALCIUM ION 9 107 0.0004187 0.003319
588 REGULATION OF DEVELOPMENTAL GROWTH 16 289 0.0004216 0.003336
589 POSITIVE REGULATION OF TELOMERE MAINTENANCE 6 47 0.0004235 0.00334
590 POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS 6 47 0.0004235 0.00334
591 RIBONUCLEOPROTEIN COMPLEX BIOGENESIS 21 440 0.0004283 0.003372
592 VIRAL LIFE CYCLE 16 290 0.0004378 0.003441
593 PROTEIN STABILIZATION 10 131 0.0004437 0.003481
594 POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY 4 18 0.0004603 0.003588
595 POSITIVE REGULATION OF DEVELOPMENTAL GROWTH 11 156 0.0004603 0.003588
596 NEGATIVE REGULATION OF RESPONSE TO WOUNDING 11 156 0.0004603 0.003588
597 LYMPHOCYTE APOPTOTIC PROCESS 4 18 0.0004603 0.003588
598 DIGESTIVE TRACT MORPHOGENESIS 6 48 0.0004756 0.0037
599 NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT 8 87 0.0004786 0.003718
600 GERM CELL DEVELOPMENT 13 209 0.0004874 0.00378
601 ENDOCARDIAL CUSHION DEVELOPMENT 5 32 0.0004977 0.00384
602 REGULATION OF TELOMERE MAINTENANCE 7 67 0.0004964 0.00384
603 REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA 5 32 0.0004977 0.00384
604 NEGATIVE REGULATION OF CELL ACTIVATION 11 158 0.0005127 0.00395
605 POSITIVE REGULATION OF GROWTH 14 238 0.0005247 0.004035
606 MORPHOGENESIS OF EMBRYONIC EPITHELIUM 10 134 0.0005308 0.004075
607 POST EMBRYONIC DEVELOPMENT 8 89 0.0005579 0.004276
608 VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION 4 19 0.0005734 0.004345
609 CELLULAR RESPONSE TO GAMMA RADIATION 4 19 0.0005734 0.004345
610 REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION 4 19 0.0005734 0.004345
611 PEPTIDYL ARGININE MODIFICATION 4 19 0.0005734 0.004345
612 MITOTIC G2 M TRANSITION CHECKPOINT 4 19 0.0005734 0.004345
613 POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION 4 19 0.0005734 0.004345
614 ATRIOVENTRICULAR VALVE DEVELOPMENT 4 19 0.0005734 0.004345
615 CELLULAR SENESCENCE 5 33 0.0005765 0.004353
616 REGULATION OF RESPONSE TO EXTERNAL STIMULUS 35 926 0.0005773 0.004353
617 POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING 5 33 0.0005765 0.004353
618 ESTABLISHMENT OF LOCALIZATION IN CELL 55 1676 0.0005865 0.004416
619 LYMPHOCYTE HOMEOSTASIS 6 50 0.0005946 0.004462
620 REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING 6 50 0.0005946 0.004462
621 NEGATIVE REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 10 136 0.0005963 0.004468
622 NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY 8 90 0.0006013 0.004498
623 NUCLEOTIDE EXCISION REPAIR 9 113 0.0006246 0.004665
624 CELL CHEMOTAXIS 11 162 0.0006324 0.004708
625 NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY 11 162 0.0006324 0.004708
626 CELLULAR RESPONSE TO LIGHT STIMULUS 8 91 0.0006474 0.004812
627 MUSCLE ORGAN MORPHOGENESIS 7 70 0.0006485 0.004813
628 POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION 6 51 0.0006621 0.004898
629 CELLULAR RESPONSE TO FATTY ACID 6 51 0.0006621 0.004898
630 HEART VALVE DEVELOPMENT 5 34 0.0006644 0.004907
631 SINGLE ORGANISM CELLULAR LOCALIZATION 34 898 0.0006705 0.004944
632 REGULATION OF PROTEIN COMPLEX DISASSEMBLY 13 217 0.0006936 0.005107
633 MESENCHYME DEVELOPMENT 12 190 0.0006949 0.005108
634 INNER EAR MORPHOGENESIS 8 92 0.0006964 0.005111
635 NEGATIVE REGULATION OF CELL CYCLE ARREST 4 20 0.000705 0.005125
636 GENETIC IMPRINTING 4 20 0.000705 0.005125
637 PROTEIN REFOLDING 4 20 0.000705 0.005125
638 BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS 4 20 0.000705 0.005125
639 MYELOID DENDRITIC CELL DIFFERENTIATION 4 20 0.000705 0.005125
640 INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY 4 20 0.000705 0.005125
641 SKIN EPIDERMIS DEVELOPMENT 7 71 0.0007067 0.00513
642 POSITIVE REGULATION OF REPRODUCTIVE PROCESS 6 52 0.0007354 0.005314
643 NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS 6 52 0.0007354 0.005314
644 CELLULAR RESPONSE TO IONIZING RADIATION 6 52 0.0007354 0.005314
645 EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS 8 93 0.0007482 0.005389
646 CARDIAC MUSCLE TISSUE DEVELOPMENT 10 140 0.0007476 0.005389
647 REGULATION OF DNA BIOSYNTHETIC PROCESS 8 94 0.0008032 0.005776
648 MAMMARY GLAND EPITHELIUM DEVELOPMENT 6 53 0.0008149 0.005851
649 PANCREAS DEVELOPMENT 7 73 0.0008355 0.005962
650 REGULATION OF ORGAN GROWTH 7 73 0.0008355 0.005962
651 CONNECTIVE TISSUE DEVELOPMENT 12 194 0.0008344 0.005962
652 REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION 7 73 0.0008355 0.005962
653 TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 8 95 0.0008613 0.006128
654 CHROMATIN SILENCING 8 95 0.0008613 0.006128
655 NEGATIVE REGULATION OF REPRODUCTIVE PROCESS 6 54 0.0009008 0.006379
656 CARDIAC MUSCLE TISSUE MORPHOGENESIS 6 54 0.0009008 0.006379
657 REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL 6 54 0.0009008 0.006379
658 VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 7 74 0.0009064 0.00641
659 CELLULAR CATABOLIC PROCESS 45 1322 0.0009126 0.006444
660 FEMALE GAMETE GENERATION 8 96 0.0009228 0.006506
661 CARDIAC CHAMBER DEVELOPMENT 10 144 0.0009292 0.006538
662 PROTEIN FOLDING 13 224 0.0009301 0.006538
663 NEGATIVE REGULATION OF PROTEIN COMPLEX DISASSEMBLY 11 170 0.0009421 0.006612
664 MUSCLE SYSTEM PROCESS 15 282 0.0009504 0.00666
665 NEGATIVE REGULATION OF WNT SIGNALING PATHWAY 12 197 0.0009537 0.006673
666 REGULATION OF BIOMINERAL TISSUE DEVELOPMENT 7 75 0.000982 0.006861
667 HINDLIMB MORPHOGENESIS 5 37 0.0009887 0.006866
668 REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION 5 37 0.0009887 0.006866
669 ESTABLISHMENT OR MAINTENANCE OF APICAL BASAL CELL POLARITY 5 37 0.0009887 0.006866
670 ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY 5 37 0.0009887 0.006866
671 CRANIAL SKELETAL SYSTEM DEVELOPMENT 6 55 0.0009935 0.006889
672 METHYLATION 15 284 0.00102 0.007065
673 REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS 4 22 0.00103 0.007067
674 SEX DETERMINATION 4 22 0.00103 0.007067
675 RRNA METABOLIC PROCESS 14 255 0.001028 0.007067
676 REGULATION OF HEMOPOIESIS 16 314 0.001026 0.007067
677 AORTA MORPHOGENESIS 4 22 0.00103 0.007067
678 POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT 4 22 0.00103 0.007067
679 REGULATION OF ENDOCYTOSIS 12 199 0.001041 0.007133
680 REGULATION OF PROTEIN TARGETING TO MITOCHONDRION 8 98 0.001056 0.007206
681 POSITIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS 8 98 0.001056 0.007206
682 NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 8 98 0.001056 0.007206
683 EXTRACELLULAR MATRIX DISASSEMBLY 7 76 0.001063 0.007239
684 REGULATION OF MUSCLE CONTRACTION 10 147 0.001088 0.0074
685 ACTIN MYOSIN FILAMENT SLIDING 5 38 0.001119 0.007569
686 SUBSTRATE ADHESION DEPENDENT CELL SPREADING 5 38 0.001119 0.007569
687 MUSCLE FILAMENT SLIDING 5 38 0.001119 0.007569
688 POSITIVE REGULATION OF ORGAN GROWTH 5 38 0.001119 0.007569
689 REGULATION OF ION HOMEOSTASIS 12 201 0.001135 0.007663
690 CIRCADIAN REGULATION OF GENE EXPRESSION 6 57 0.001201 0.008085
691 PEPTIDYL PROLINE MODIFICATION 6 57 0.001201 0.008085
692 MODIFICATION OF MORPHOLOGY OR PHYSIOLOGY OF OTHER ORGANISM 8 100 0.001205 0.008089
693 NEGATIVE REGULATION OF INFLAMMATORY RESPONSE 8 100 0.001205 0.008089
694 REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 18 381 0.001212 0.008124
695 POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 15 289 0.001215 0.008132
696 POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL METABOLIC PROCESS 4 23 0.001226 0.008173
697 POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS 4 23 0.001226 0.008173
698 POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS 4 23 0.001226 0.008173
699 LEUKOCYTE ACTIVATION 19 414 0.001256 0.008361
700 ANATOMICAL STRUCTURE MATURATION 5 39 0.001262 0.008364
701 PLATELET AGGREGATION 5 39 0.001262 0.008364
702 GLANDULAR EPITHELIAL CELL DIFFERENTIATION 5 39 0.001262 0.008364
703 POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT 13 232 0.00128 0.00847
704 ORGANELLE LOCALIZATION 19 415 0.001291 0.008536
705 MITOCHONDRIAL TRANSPORT 11 177 0.001307 0.008628
706 REGULATION OF DNA RECOMBINATION 6 58 0.001316 0.008636
707 RESPONSE TO ENDOPLASMIC RETICULUM STRESS 13 233 0.00133 0.008636
708 ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME 3 11 0.001329 0.008636
709 POSITIVE REGULATION OF HORMONE METABOLIC PROCESS 3 11 0.001329 0.008636
710 NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 14 262 0.001331 0.008636
711 REGULATION OF INTERLEUKIN 1 PRODUCTION 6 58 0.001316 0.008636
712 ORGANELLE INHERITANCE 3 11 0.001329 0.008636
713 PROSTATE GLAND GROWTH 3 11 0.001329 0.008636
714 EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION 3 11 0.001329 0.008636
715 EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT 3 11 0.001329 0.008636
716 REGULATION OF HISTONE H4 ACETYLATION 3 11 0.001329 0.008636
717 PROSTATE GLANDULAR ACINUS DEVELOPMENT 3 11 0.001329 0.008636
718 PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS 7 79 0.001335 0.008655
719 RESPONSE TO INSULIN 12 205 0.001343 0.008692
720 REGULATION OF WOUND HEALING 9 126 0.001359 0.008781
721 REGULATION OF LEUKOCYTE PROLIFERATION 12 206 0.0014 0.009035
722 MAMMARY GLAND MORPHOGENESIS 5 40 0.001418 0.009111
723 ENDOCRINE PANCREAS DEVELOPMENT 5 40 0.001418 0.009111
724 CELL PROJECTION ORGANIZATION 33 902 0.001417 0.009111
725 REGULATION OF G PROTEIN COUPLED RECEPTOR PROTEIN SIGNALING PATHWAY 9 127 0.001436 0.009203
726 NEGATIVE REGULATION OF ION TRANSPORT 9 127 0.001436 0.009203
727 REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY 6 59 0.00144 0.009214
728 HYPOTHALAMUS DEVELOPMENT 4 24 0.001447 0.00925
729 REGULATION OF PROTEIN UBIQUITINATION INVOLVED IN UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS 8 103 0.001458 0.009298
730 POSITIVE REGULATION OF MAP KINASE ACTIVITY 12 207 0.001459 0.009298
731 POSITIVE REGULATION OF LOCOMOTION 19 420 0.001482 0.009434
732 SECRETION BY CELL 21 486 0.001506 0.009572
733 DNA REPLICATION 12 208 0.00152 0.009633
734 REGULATION OF CATION TRANSMEMBRANE TRANSPORT 12 208 0.00152 0.009633
735 NEGATIVE REGULATION OF CELL DIVISION 6 60 0.001572 0.00991
736 STEM CELL PROLIFERATION 6 60 0.001572 0.00991
737 POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION 6 60 0.001572 0.00991
738 LEUKOCYTE HOMEOSTASIS 6 60 0.001572 0.00991
739 REGULATION OF CALCIUM ION TRANSPORT 12 209 0.001582 0.009963
740 MITOTIC SPINDLE ASSEMBLY 5 41 0.001587 0.009967
741 MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS 5 41 0.001587 0.009967
NumGOOverlapSizeP ValueAdj. P Value
1 ENZYME BINDING 109 1737 2.761e-26 2.565e-23
2 MACROMOLECULAR COMPLEX BINDING 92 1399 2.168e-23 1.007e-20
3 TRANSCRIPTION FACTOR ACTIVITY PROTEIN BINDING 57 588 2.734e-22 8.468e-20
4 TRANSCRIPTION FACTOR BINDING 48 524 7.202e-18 1.673e-15
5 KINASE BINDING 51 606 2.254e-17 4.188e-15
6 SEQUENCE SPECIFIC DNA BINDING 68 1037 3.633e-17 5.625e-15
7 CHROMATIN BINDING 42 435 1.457e-16 1.933e-14
8 PROTEIN KINASE ACTIVITY 49 640 4.259e-15 4.946e-13
9 KINASE ACTIVITY 55 842 6.382e-14 6.587e-12
10 REGULATORY REGION NUCLEIC ACID BINDING 53 818 2.641e-13 2.231e-11
11 DOUBLE STRANDED DNA BINDING 51 764 2.499e-13 2.231e-11
12 CORE PROMOTER BINDING 22 152 9.991e-13 7.684e-11
13 TRANSCRIPTION COACTIVATOR ACTIVITY 30 296 1.075e-12 7.684e-11
14 RNA BINDING 78 1598 1.328e-12 8.81e-11
15 POLY A RNA BINDING 64 1170 1.524e-12 9.438e-11
16 PROTEIN COMPLEX BINDING 54 935 1.379e-11 7.851e-10
17 ADENYL NUCLEOTIDE BINDING 73 1514 1.437e-11 7.851e-10
18 PROTEIN SERINE THREONINE KINASE ACTIVITY 35 445 2.084e-11 1.076e-09
19 TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS 55 992 4.168e-11 2.038e-09
20 HORMONE RECEPTOR BINDING 21 168 5.739e-11 2.609e-09
21 RIBONUCLEOTIDE BINDING 82 1860 5.898e-11 2.609e-09
22 STEROID HORMONE RECEPTOR BINDING 15 81 1.183e-10 4.995e-09
23 IDENTICAL PROTEIN BINDING 61 1209 1.499e-10 6.054e-09
24 PROTEIN DIMERIZATION ACTIVITY 57 1149 1.217e-09 4.713e-08
25 STRUCTURE SPECIFIC DNA BINDING 16 118 3.427e-09 1.274e-07
26 RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY SEQUENCE SPECIFIC DNA BINDING 37 629 1.766e-08 6.308e-07
27 CORE PROMOTER PROXIMAL REGION DNA BINDING 27 371 2.285e-08 7.864e-07
28 CORE PROMOTER SEQUENCE SPECIFIC DNA BINDING 14 101 2.473e-08 8.206e-07
29 NUCLEIC ACID BINDING TRANSCRIPTION FACTOR ACTIVITY 55 1199 3.68e-08 1.179e-06
30 PROTEIN DOMAIN SPECIFIC BINDING 36 624 4.535e-08 1.404e-06
31 ENHANCER BINDING 13 93 7.073e-08 2.12e-06
32 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 24 328 1.264e-07 3.671e-06
33 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING 23 315 2.408e-07 6.78e-06
34 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 19 226 3.211e-07 8.772e-06
35 PROTEIN HOMODIMERIZATION ACTIVITY 37 722 5.622e-07 1.451e-05
36 RECEPTOR BINDING 60 1476 5.578e-07 1.451e-05
37 PROTEIN HETERODIMERIZATION ACTIVITY 28 468 7.293e-07 1.831e-05
38 RNA POLYMERASE II DISTAL ENHANCER SEQUENCE SPECIFIC DNA BINDING 10 65 9.369e-07 2.291e-05
39 RNA POLYMERASE II CORE PROMOTER SEQUENCE SPECIFIC DNA BINDING 9 53 1.398e-06 3.248e-05
40 LIGAND DEPENDENT NUCLEAR RECEPTOR TRANSCRIPTION COACTIVATOR ACTIVITY 9 53 1.398e-06 3.248e-05
41 HISTONE KINASE ACTIVITY 6 19 1.756e-06 3.98e-05
42 RNA POLYMERASE II TRANSCRIPTION FACTOR BINDING 12 104 1.857e-06 4.108e-05
43 PROTEIN C TERMINUS BINDING 16 186 2.031e-06 4.387e-05
44 NUCLEOSOMAL DNA BINDING 7 30 2.261e-06 4.774e-05
45 PROTEIN DEACETYLASE ACTIVITY 8 43 2.648e-06 5.466e-05
46 UBIQUITIN LIKE PROTEIN LIGASE BINDING 19 264 3.334e-06 6.732e-05
47 TRANSCRIPTION COREPRESSOR ACTIVITY 17 221 4.508e-06 8.911e-05
48 RIBONUCLEOPROTEIN COMPLEX BINDING 11 95 4.82e-06 9.329e-05
49 CHROMATIN DNA BINDING 10 80 6.517e-06 0.0001236
50 ANDROGEN RECEPTOR BINDING 7 39 1.452e-05 0.0002698
51 DEOXYRIBONUCLEASE ACTIVITY 9 70 1.499e-05 0.000273
52 RECEPTOR SIGNALING PROTEIN ACTIVITY 14 172 1.657e-05 0.000296
53 HEAT SHOCK PROTEIN BINDING 10 89 1.703e-05 0.0002974
54 ESTROGEN RECEPTOR BINDING 7 40 1.729e-05 0.0002974
55 DEACETYLASE ACTIVITY 8 55 1.785e-05 0.0003015
56 NAD DEPENDENT PROTEIN DEACETYLASE ACTIVITY 5 17 1.981e-05 0.0003286
57 BHLH TRANSCRIPTION FACTOR BINDING 6 28 2.079e-05 0.0003388
58 PROTEIN TYROSINE KINASE ACTIVITY 14 176 2.146e-05 0.0003437
59 ENZYME REGULATOR ACTIVITY 40 959 2.843e-05 0.0004476
60 ADRENERGIC RECEPTOR BINDING 5 19 3.595e-05 0.0005567
61 NUCLEOSOME BINDING 7 45 3.845e-05 0.0005856
62 CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY 6 34 6.673e-05 0.0009998
63 HISTONE DEACETYLASE BINDING 10 105 7.178e-05 0.001058
64 PROTEIN KINASE C BINDING 7 50 7.735e-05 0.001123
65 TAU PROTEIN KINASE ACTIVITY 4 12 8.226e-05 0.001158
66 HISTONE DEACETYLASE ACTIVITY H3 K14 SPECIFIC 4 12 8.226e-05 0.001158
67 DRUG BINDING 10 109 9.85e-05 0.001366
68 MOLECULAR FUNCTION REGULATOR 49 1353 0.0001289 0.001761
69 RECEPTOR SIGNALING PROTEIN SERINE THREONINE KINASE ACTIVITY 9 92 0.0001336 0.001798
70 SINGLE STRANDED DNA BINDING 9 93 0.0001452 0.001927
71 ATPASE BINDING 8 76 0.0001886 0.002467
72 HISTONE METHYLTRANSFERASE ACTIVITY 7 58 0.0002017 0.002602
73 CYTOSKELETAL PROTEIN BINDING 33 819 0.000272 0.003462
74 TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY 8 81 0.0002937 0.003687
75 UBIQUITIN LIKE PROTEIN CONJUGATING ENZYME ACTIVITY 5 29 0.000309 0.003828
76 PROTEIN METHYLTRANSFERASE ACTIVITY 8 82 0.0003196 0.003907
77 CIS TRANS ISOMERASE ACTIVITY 6 45 0.0003328 0.004015
78 DAMAGED DNA BINDING 7 63 0.0003393 0.004041
79 TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY 7 64 0.0003742 0.004378
80 HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN LINEAR AMIDES 8 84 0.000377 0.004378
81 MACROLIDE BINDING 4 18 0.0004603 0.005214
82 FK506 BINDING 4 18 0.0004603 0.005214
83 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION FACTOR BINDING 10 133 0.0005003 0.0056
84 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II DISTAL ENHANCER SEQUENCE SPECIFIC BINDING 8 90 0.0006013 0.00665
85 RNA POLYMERASE II TRANSCRIPTION COFACTOR ACTIVITY 8 91 0.0006474 0.007076
86 ENDODEOXYRIBONUCLEASE ACTIVITY 6 51 0.0006621 0.007152
NumGOOverlapSizeP ValueAdj. P Value
1 CHROMOSOME 64 880 2.157e-18 1.26e-15
2 NUCLEAR CHROMOSOME 48 523 6.666e-18 1.947e-15
3 CHROMATIN 40 441 6.647e-15 1.294e-12
4 NUCLEOPLASM PART 50 708 5.139e-14 7.503e-12
5 TRANSCRIPTION FACTOR COMPLEX 30 298 1.28e-12 1.495e-10
6 NUCLEAR CHROMATIN 28 291 2.171e-11 2.113e-09
7 NUCLEAR TRANSCRIPTION FACTOR COMPLEX 18 127 1.693e-10 1.413e-08
8 RNA POLYMERASE II TRANSCRIPTION FACTOR COMPLEX 16 101 3.257e-10 2.378e-08
9 CYTOSKELETAL PART 67 1436 4.627e-10 3.002e-08
10 SPINDLE 25 289 2.436e-09 1.423e-07
11 CATALYTIC COMPLEX 52 1038 5.086e-09 2.7e-07
12 CONDENSED CHROMOSOME 20 195 5.56e-09 2.706e-07
13 CHROMOSOMAL REGION 26 330 8.286e-09 3.722e-07
14 NUCLEOLUS 45 848 1.099e-08 4.585e-07
15 MICROTUBULE CYTOSKELETON 52 1068 1.315e-08 5.12e-07
16 CYTOSKELETON 77 1967 4.959e-08 1.703e-06
17 METHYLTRANSFERASE COMPLEX 13 90 4.74e-08 1.703e-06
18 CONDENSED NUCLEAR CHROMOSOME 12 85 2.022e-07 6.561e-06
19 HISTONE METHYLTRANSFERASE COMPLEX 11 71 2.479e-07 7.62e-06
20 PERINUCLEAR REGION OF CYTOPLASM 35 642 2.739e-07 7.999e-06
21 PRONUCLEUS 6 15 3.479e-07 9.676e-06
22 SPINDLE POLE 14 126 4.132e-07 1.097e-05
23 RIBONUCLEOPROTEIN COMPLEX 37 721 5.438e-07 1.381e-05
24 TRANSFERASE COMPLEX 36 703 8.189e-07 1.993e-05
25 MICROTUBULE ORGANIZING CENTER 33 623 1.149e-06 2.684e-05
26 CHROMOSOME TELOMERIC REGION 15 162 1.689e-06 3.795e-05
27 CELL SUBSTRATE JUNCTION 24 398 3.993e-06 8.638e-05
28 HETEROCHROMATIN 9 67 1.042e-05 0.0002172
29 MYELIN SHEATH 14 168 1.268e-05 0.0002554
30 CENTROSOME 26 487 1.401e-05 0.0002728
31 NEURON PROJECTION 40 942 1.898e-05 0.0003576
32 MIDBODY 12 132 2.215e-05 0.0004042
33 NEURON PART 49 1265 2.429e-05 0.0004298
34 CONDENSED NUCLEAR CHROMOSOME CENTROMERIC REGION 5 18 2.695e-05 0.0004497
35 SPINDLE MICROTUBULE 8 58 2.66e-05 0.0004497
36 H4 HISTONE ACETYLTRANSFERASE COMPLEX 5 19 3.595e-05 0.0005729
37 PML BODY 10 97 3.63e-05 0.0005729
38 NUCLEAR MATRIX 10 98 3.968e-05 0.0006098
39 ANCHORING JUNCTION 25 489 4.182e-05 0.0006263
40 NUCLEAR HETEROCHROMATIN 6 32 4.658e-05 0.0006801
41 CELL BODY 25 494 4.931e-05 0.0006857
42 NUCLEAR PERIPHERY 11 121 4.848e-05 0.0006857
43 NUCLEAR BODY 20 349 5.208e-05 0.0006912
44 EXTRACELLULAR SPACE 51 1376 5.187e-05 0.0006912
45 SUPRAMOLECULAR FIBER 30 670 8.507e-05 0.001104
46 NUCLEAR CHROMOSOME TELOMERIC REGION 11 132 0.0001071 0.001359
47 EXTRINSIC COMPONENT OF PLASMA MEMBRANE 11 136 0.0001398 0.001737
48 MITOTIC SPINDLE 7 55 0.0001436 0.001748
49 MICROVILLUS 8 75 0.0001718 0.002036
50 CELL PROJECTION 60 1786 0.0001743 0.002036
51 DNA DIRECTED RNA POLYMERASE II HOLOENZYME 9 97 0.0002004 0.002295
52 SEX CHROMOSOME 5 27 0.0002174 0.002442
53 MLL1 2 COMPLEX 5 28 0.0002602 0.002867
54 CONDENSED CHROMOSOME CENTROMERIC REGION 9 102 0.0002931 0.00317
55 CHROMOSOME CENTROMERIC REGION 12 174 0.0003152 0.003347
56 CELL PROJECTION PART 36 946 0.0004256 0.004438
57 RUFFLE 11 156 0.0004603 0.004717
58 MICROVILLUS MEMBRANE 4 19 0.0005734 0.005774
59 SOMATODENDRITIC COMPARTMENT 27 650 0.0006163 0.006101
60 INCLUSION BODY 7 70 0.0006485 0.006219
61 CELL JUNCTION 41 1151 0.0006495 0.006219
62 SWI SNF SUPERFAMILY TYPE COMPLEX 7 71 0.0007067 0.006657
63 CYTOSOLIC PART 13 223 0.0008927 0.008275
64 CYTOPLASMIC SIDE OF MEMBRANE 11 170 0.0009421 0.008596
65 KINETOCHORE 9 120 0.0009627 0.008649
66 EXTRINSIC COMPONENT OF CYTOPLASMIC SIDE OF PLASMA MEMBRANE 8 98 0.001056 0.009346
67 RNA POLYMERASE COMPLEX 9 122 0.001083 0.009436
68 INTRACELLULAR VESICLE 43 1259 0.001112 0.009549
69 RIBONUCLEOPROTEIN GRANULE 10 148 0.001145 0.009694

Over-represented Pathway

NumPathwayPathviewOverlapSizeP ValueAdj. P Value
1 Cell_cycle_hsa04110 26 124 6.264e-19 3.257e-17
2 Cellular_senescence_hsa04218 21 160 2.244e-11 5.833e-10
3 p53_signaling_pathway_hsa04115 12 68 1.543e-08 2.674e-07
4 Oocyte_meiosis_hsa04114 14 124 3.388e-07 4.404e-06
5 Apoptosis_hsa04210 14 138 1.258e-06 1.308e-05
6 Rap1_signaling_pathway_hsa04015 17 206 1.733e-06 1.502e-05
7 PI3K_Akt_signaling_pathway_hsa04151 22 352 5.725e-06 4.087e-05
8 Notch_signaling_pathway_hsa04330 8 48 6.288e-06 4.087e-05
9 MAPK_signaling_pathway_hsa04010 19 295 1.631e-05 9.426e-05
10 Focal_adhesion_hsa04510 15 199 2.08e-05 0.0001063
11 Hippo_signaling_pathway_hsa04390 13 154 2.249e-05 0.0001063
12 Apoptosis_multiple_species_hsa04215 6 33 5.593e-05 0.0002424
13 Regulation_of_actin_cytoskeleton_hsa04810 14 208 0.0001322 0.0005287
14 VEGF_signaling_pathway_hsa04370 7 59 0.0002247 0.0008347
15 Ras_signaling_pathway_hsa04014 14 232 0.0004066 0.00141
16 FoxO_signaling_pathway_hsa04068 10 132 0.0004713 0.001532
17 Signaling_pathways_regulating_pluripotency_of_stem_cells_hsa04550 9 139 0.002669 0.008163
18 Hedgehog_signaling_pathway_hsa04340 5 47 0.002933 0.008472
19 cAMP_signaling_pathway_hsa04024 11 198 0.003151 0.008624
20 Wnt_signaling_pathway_hsa04310 9 146 0.003705 0.009632
21 HIF_1_signaling_pathway_hsa04066 7 100 0.005079 0.01258
22 TGF_beta_signaling_pathway_hsa04350 6 84 0.008402 0.01986
23 ErbB_signaling_pathway_hsa04012 6 85 0.008884 0.02009
24 Gap_junction_hsa04540 6 88 0.01045 0.02265
25 Endocytosis_hsa04144 11 244 0.01423 0.02961
26 Sphingolipid_signaling_pathway_hsa04071 6 118 0.03798 0.07379
27 Calcium_signaling_pathway_hsa04020 8 182 0.03831 0.07379
28 Mitophagy_animal_hsa04137 4 65 0.04735 0.08793
29 Adherens_junction_hsa04520 4 72 0.06436 0.1154
30 Tight_junction_hsa04530 7 170 0.06722 0.1165
31 mTOR_signaling_pathway_hsa04150 6 151 0.09833 0.1649
32 Hippo_signaling_pathway_multiple_species_hsa04392 2 29 0.1229 0.1997
33 NF_kappa_B_signaling_pathway_hsa04064 4 95 0.1387 0.2186
34 Apelin_signaling_pathway_hsa04371 5 137 0.1608 0.246
35 TNF_signaling_pathway_hsa04668 4 108 0.1911 0.2779
36 Phospholipase_D_signaling_pathway_hsa04072 5 146 0.1924 0.2779
37 Phagosome_hsa04145 5 152 0.2145 0.3015
38 AMPK_signaling_pathway_hsa04152 4 121 0.2485 0.323
39 Jak_STAT_signaling_pathway_hsa04630 5 162 0.253 0.323
40 cGMP_PKG_signaling_pathway_hsa04022 5 163 0.2569 0.323
41 Lysosome_hsa04142 4 123 0.2577 0.323
42 Necroptosis_hsa04217 5 164 0.2609 0.323
43 Autophagy_animal_hsa04140 4 128 0.2809 0.3396
44 ECM_receptor_interaction_hsa04512 2 82 0.5151 0.6087
45 Neuroactive_ligand_receptor_interaction_hsa04080 6 278 0.528 0.6102
46 Phosphatidylinositol_signaling_system_hsa04070 2 99 0.6173 0.6978
47 Cytokine_cytokine_receptor_interaction_hsa04060 5 270 0.6706 0.742

lncRNA-mediated sponge

(Download full result)

Num lncRNA miRNAs           miRNAs count     Gene Sponge regulatory network lncRNA log2FC lncRNA pvalue Gene log2FC Gene pvalue lncRNA-gene Pearson correlation
1 RP11-513G11.3 hsa-miR-106b-5p;hsa-miR-125a-3p;hsa-miR-132-3p;hsa-miR-149-5p;hsa-miR-17-5p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-181c-5p;hsa-miR-200a-3p;hsa-miR-200a-5p;hsa-miR-20b-5p;hsa-miR-212-3p;hsa-miR-2355-3p;hsa-miR-301a-3p;hsa-miR-338-3p;hsa-miR-9-5p;hsa-miR-93-5p 17 AR Sponge network -2.342 5.0E-5 -2.655 0 0.644
2 RP11-12A2.3 hsa-miR-106b-5p;hsa-miR-132-3p;hsa-miR-141-3p;hsa-miR-146a-5p;hsa-miR-148b-3p;hsa-miR-148b-5p;hsa-miR-149-5p;hsa-miR-155-5p;hsa-miR-17-5p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-181c-5p;hsa-miR-185-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200a-3p;hsa-miR-200a-5p;hsa-miR-20a-5p;hsa-miR-212-3p;hsa-miR-2355-5p;hsa-miR-301a-3p;hsa-miR-30d-5p;hsa-miR-335-3p;hsa-miR-338-3p;hsa-miR-432-5p;hsa-miR-660-5p;hsa-miR-877-5p;hsa-miR-93-5p 28 AR Sponge network -4.779 0 -2.655 0 0.594
3 TPRG1-AS1 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-125a-3p;hsa-miR-149-5p;hsa-miR-17-5p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-181c-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-223-3p;hsa-miR-2355-3p;hsa-miR-338-3p;hsa-miR-629-3p;hsa-miR-93-5p 16 AR Sponge network -0.756 0.03021 -2.655 0 0.594
4 RP4-539M6.20 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-125a-3p;hsa-miR-141-3p;hsa-miR-146a-5p;hsa-miR-148b-5p;hsa-miR-17-5p;hsa-miR-200a-3p;hsa-miR-200a-5p;hsa-miR-20a-5p;hsa-miR-301a-3p 11 AR Sponge network -1.177 0.00034 -2.655 0 0.581
5 LINC01018 hsa-miR-106b-5p;hsa-miR-125a-3p;hsa-miR-132-3p;hsa-miR-141-3p;hsa-miR-146a-5p;hsa-miR-148b-3p;hsa-miR-148b-5p;hsa-miR-155-5p;hsa-miR-17-5p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-181c-5p;hsa-miR-19a-3p;hsa-miR-200a-3p;hsa-miR-200a-5p;hsa-miR-20a-5p;hsa-miR-212-3p;hsa-miR-2355-3p;hsa-miR-2355-5p;hsa-miR-301a-3p;hsa-miR-320a;hsa-miR-335-3p;hsa-miR-338-3p;hsa-miR-370-3p;hsa-miR-421;hsa-miR-432-5p;hsa-miR-629-3p;hsa-miR-877-5p;hsa-miR-93-5p 29 AR Sponge network -3.231 0 -2.655 0 0.569
6 RP11-418J17.3 hsa-miR-106b-5p;hsa-miR-125a-3p;hsa-miR-149-5p;hsa-miR-155-5p;hsa-miR-17-5p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-181c-5p;hsa-miR-200a-5p;hsa-miR-301a-3p 10 AR Sponge network -2.047 0.00048 -2.655 0 0.56
7 RP11-659E9.2 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-125a-3p;hsa-miR-149-5p;hsa-miR-155-5p;hsa-miR-17-5p;hsa-miR-181b-5p;hsa-miR-181c-5p;hsa-miR-20a-5p;hsa-miR-20b-5p;hsa-miR-301a-3p;hsa-miR-335-3p;hsa-miR-338-3p;hsa-miR-454-3p 14 AR Sponge network -2.179 0.00022 -2.655 0 0.541
8 RP11-104J23.1 hsa-miR-125a-3p;hsa-miR-132-3p;hsa-miR-149-5p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-181c-5p;hsa-miR-200a-5p;hsa-miR-212-3p;hsa-miR-2355-3p;hsa-miR-2355-5p;hsa-miR-335-3p 11 AR Sponge network -1.195 0.00749 -2.655 0 0.535
9 RP11-119D9.1 hsa-miR-106b-5p;hsa-miR-125a-3p;hsa-miR-132-3p;hsa-miR-141-3p;hsa-miR-148b-3p;hsa-miR-149-5p;hsa-miR-155-5p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-181c-5p;hsa-miR-200a-3p;hsa-miR-200a-5p;hsa-miR-212-3p;hsa-miR-2355-3p;hsa-miR-2355-5p;hsa-miR-301a-3p;hsa-miR-320a;hsa-miR-335-3p;hsa-miR-338-3p;hsa-miR-629-3p;hsa-miR-93-5p 21 AR Sponge network -2.765 0 -2.655 0 0.534
10 CTD-2194A8.2 hsa-miR-106b-5p;hsa-miR-125a-3p;hsa-miR-136-3p;hsa-miR-141-3p;hsa-miR-149-5p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-181c-5p;hsa-miR-200a-3p;hsa-miR-223-3p;hsa-miR-2355-3p;hsa-miR-2355-5p;hsa-miR-301a-3p 13 AR Sponge network -0.829 0.11289 -2.655 0 0.524
11 CTC-297N7.9 hsa-miR-125a-3p;hsa-miR-148b-3p;hsa-miR-148b-5p;hsa-miR-149-5p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-181c-5p;hsa-miR-185-5p;hsa-miR-2355-3p;hsa-miR-2355-5p;hsa-miR-301a-3p;hsa-miR-338-3p;hsa-miR-877-5p;hsa-miR-9-5p 14 AR Sponge network -1.632 0 -2.655 0 0.52
12 LINC00238 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-125a-3p;hsa-miR-132-3p;hsa-miR-141-3p;hsa-miR-148b-3p;hsa-miR-148b-5p;hsa-miR-149-5p;hsa-miR-155-5p;hsa-miR-17-5p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-181c-5p;hsa-miR-185-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-20b-5p;hsa-miR-212-3p;hsa-miR-301a-3p;hsa-miR-338-3p;hsa-miR-502-5p;hsa-miR-629-3p;hsa-miR-660-5p 24 AR Sponge network -4.997 0 -2.655 0 0.52
13 DHRS4-AS1 hsa-miR-106b-5p;hsa-miR-132-3p;hsa-miR-148b-5p;hsa-miR-149-5p;hsa-miR-17-5p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-181c-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-2355-5p;hsa-miR-301a-3p;hsa-miR-421;hsa-miR-502-5p;hsa-miR-660-5p;hsa-miR-877-5p 17 AR Sponge network -0.646 0.01829 -2.655 0 0.515
14 AL161668.5 hsa-miR-106b-5p;hsa-miR-125a-3p;hsa-miR-148b-3p;hsa-miR-149-5p;hsa-miR-17-5p;hsa-miR-20a-5p;hsa-miR-223-3p;hsa-miR-338-3p;hsa-miR-421;hsa-miR-93-5p 10 AR Sponge network -2.699 0 -2.655 0 0.512
15 RP11-434D9.1 hsa-miR-106b-5p;hsa-miR-125a-3p;hsa-miR-132-3p;hsa-miR-146a-5p;hsa-miR-17-5p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-181c-5p;hsa-miR-200a-3p;hsa-miR-200a-5p;hsa-miR-20a-5p;hsa-miR-212-3p;hsa-miR-301a-3p;hsa-miR-338-3p;hsa-miR-370-3p;hsa-miR-421;hsa-miR-429;hsa-miR-432-5p;hsa-miR-629-3p;hsa-miR-9-5p 20 AR Sponge network -2.913 0 -2.655 0 0.504
16 LINC00261 hsa-miR-106b-5p;hsa-miR-125a-3p;hsa-miR-132-3p;hsa-miR-149-5p;hsa-miR-155-5p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-181c-5p;hsa-miR-212-3p;hsa-miR-2355-5p;hsa-miR-301a-3p;hsa-miR-421;hsa-miR-454-3p;hsa-miR-629-3p;hsa-miR-660-5p;hsa-miR-877-5p 16 AR Sponge network -1.194 0 -2.655 0 0.499
17 AC009166.5 hsa-miR-125a-3p;hsa-miR-132-3p;hsa-miR-149-5p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-181c-5p;hsa-miR-200a-5p;hsa-miR-212-3p;hsa-miR-2355-3p;hsa-miR-2355-5p 10 AR Sponge network -0.894 0.04713 -2.655 0 0.492
18 RP11-7M8.2 hsa-miR-106a-5p;hsa-miR-125a-3p;hsa-miR-132-3p;hsa-miR-136-5p;hsa-miR-146a-5p;hsa-miR-148b-5p;hsa-miR-149-5p;hsa-miR-17-5p;hsa-miR-200a-3p;hsa-miR-200a-5p;hsa-miR-212-3p;hsa-miR-223-3p;hsa-miR-2355-3p;hsa-miR-493-5p 14 AR Sponge network -1.367 0.138 -2.655 0 0.476
19 RP5-1103B4.3 hsa-miR-106b-5p;hsa-miR-149-5p;hsa-miR-17-5p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-181c-5p;hsa-miR-20b-5p;hsa-miR-2355-5p;hsa-miR-301a-3p;hsa-miR-9-5p 10 AR Sponge network -2.596 0 -2.655 0 0.474
20 AC004862.6 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-125a-3p;hsa-miR-132-3p;hsa-miR-148b-3p;hsa-miR-149-5p;hsa-miR-155-5p;hsa-miR-17-5p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-181c-5p;hsa-miR-19a-3p;hsa-miR-20a-5p;hsa-miR-20b-5p;hsa-miR-212-3p;hsa-miR-2355-5p;hsa-miR-301a-3p;hsa-miR-320a;hsa-miR-335-3p;hsa-miR-502-5p;hsa-miR-629-3p;hsa-miR-877-5p;hsa-miR-9-5p;hsa-miR-93-5p 24 AR Sponge network -2.202 0.00081 -2.655 0 0.47
21 CTD-3098H1.2 hsa-miR-106b-5p;hsa-miR-125a-3p;hsa-miR-146a-5p;hsa-miR-149-5p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-181c-5p;hsa-miR-200a-3p;hsa-miR-2355-3p;hsa-miR-2355-5p;hsa-miR-93-5p 11 AR Sponge network -2.236 0.0032 -2.655 0 0.464
22 RP13-650J16.1 hsa-miR-106b-5p;hsa-miR-125a-3p;hsa-miR-132-3p;hsa-miR-136-5p;hsa-miR-146a-5p;hsa-miR-149-5p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-181c-5p;hsa-miR-212-3p;hsa-miR-223-3p;hsa-miR-2355-3p;hsa-miR-370-3p;hsa-miR-93-5p 14 AR Sponge network -0.901 0.04097 -2.655 0 0.455
23 RP11-290F5.1 hsa-miR-106b-5p;hsa-miR-125a-3p;hsa-miR-132-3p;hsa-miR-146a-5p;hsa-miR-149-5p;hsa-miR-17-5p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-181c-5p;hsa-miR-200a-3p;hsa-miR-200a-5p;hsa-miR-20a-5p;hsa-miR-212-3p;hsa-miR-301a-3p;hsa-miR-335-3p;hsa-miR-338-3p;hsa-miR-421;hsa-miR-493-5p;hsa-miR-9-5p 19 AR Sponge network -1.679 5.0E-5 -2.655 0 0.454
24 RP11-963H4.3 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-125a-3p;hsa-miR-149-5p;hsa-miR-17-5p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-181c-5p;hsa-miR-20b-5p;hsa-miR-2355-3p;hsa-miR-370-3p;hsa-miR-432-5p;hsa-miR-629-3p;hsa-miR-93-5p 14 AR Sponge network -1.857 0.00116 -2.655 0 0.45
25 RP11-403I13.5 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-125a-3p;hsa-miR-132-3p;hsa-miR-141-3p;hsa-miR-146a-5p;hsa-miR-149-5p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-181c-5p;hsa-miR-200a-3p;hsa-miR-200a-5p;hsa-miR-301a-3p;hsa-miR-320a;hsa-miR-429 15 AR Sponge network -0.949 0.03877 -2.655 0 0.448
26 RP11-118B18.2 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-125a-3p;hsa-miR-149-5p;hsa-miR-17-5p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-181c-5p;hsa-miR-185-5p;hsa-miR-200a-5p;hsa-miR-20a-5p;hsa-miR-20b-5p;hsa-miR-301a-3p;hsa-miR-320a;hsa-miR-629-3p 15 AR Sponge network -2.749 0.00036 -2.655 0 0.445
27 RP11-250B2.6 hsa-miR-106b-5p;hsa-miR-132-3p;hsa-miR-17-5p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-181c-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-212-3p;hsa-miR-301a-3p;hsa-miR-30d-5p;hsa-miR-93-5p 13 AR Sponge network -0.98 2.0E-5 -2.655 0 0.44
28 RP11-407B7.1 hsa-miR-106b-5p;hsa-miR-125a-3p;hsa-miR-132-3p;hsa-miR-146a-5p;hsa-miR-149-5p;hsa-miR-155-5p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-181c-5p;hsa-miR-200a-3p;hsa-miR-200a-5p;hsa-miR-212-3p;hsa-miR-223-3p;hsa-miR-301a-3p;hsa-miR-338-3p;hsa-miR-421;hsa-miR-629-3p;hsa-miR-877-5p;hsa-miR-93-5p 19 AR Sponge network -0.818 0.00584 -2.655 0 0.44
29 RP11-372E1.4 hsa-miR-106b-5p;hsa-miR-125a-3p;hsa-miR-132-3p;hsa-miR-149-5p;hsa-miR-200a-3p;hsa-miR-200a-5p;hsa-miR-212-3p;hsa-miR-2355-3p;hsa-miR-2355-5p;hsa-miR-301a-3p;hsa-miR-335-3p;hsa-miR-877-5p;hsa-miR-93-5p 13 AR Sponge network -0.887 0.1067 -2.655 0 0.431
30 RP11-538D16.2 hsa-miR-125a-3p;hsa-miR-132-3p;hsa-miR-136-3p;hsa-miR-136-5p;hsa-miR-141-3p;hsa-miR-149-5p;hsa-miR-155-5p;hsa-miR-17-5p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-181c-5p;hsa-miR-200a-3p;hsa-miR-200a-5p;hsa-miR-223-3p;hsa-miR-2355-3p;hsa-miR-2355-5p;hsa-miR-335-3p;hsa-miR-338-3p;hsa-miR-629-3p 19 AR Sponge network 0.603 0.33218 -2.655 0 0.431
31 LDLRAD4-AS1 hsa-miR-106b-5p;hsa-miR-132-3p;hsa-miR-148b-3p;hsa-miR-148b-5p;hsa-miR-17-5p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200a-3p;hsa-miR-200a-5p;hsa-miR-20a-5p;hsa-miR-212-3p;hsa-miR-301a-3p;hsa-miR-370-3p;hsa-miR-421;hsa-miR-454-3p;hsa-miR-9-5p;hsa-miR-93-5p 19 AR Sponge network -3.366 0 -2.655 0 0.426
32 LINC00675 hsa-miR-106b-5p;hsa-miR-125a-3p;hsa-miR-132-3p;hsa-miR-149-5p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-181c-5p;hsa-miR-212-3p;hsa-miR-301a-3p;hsa-miR-338-3p;hsa-miR-421;hsa-miR-454-3p 12 AR Sponge network -2.286 0.00023 -2.655 0 0.423
33 AF064858.6 hsa-miR-106b-5p;hsa-miR-125a-3p;hsa-miR-17-5p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-19a-3p;hsa-miR-20a-5p;hsa-miR-301a-3p;hsa-miR-30d-5p;hsa-miR-335-3p;hsa-miR-338-3p;hsa-miR-421;hsa-miR-452-3p;hsa-miR-454-3p;hsa-miR-877-5p;hsa-miR-93-5p 16 AR Sponge network -2.163 0.0001 -2.655 0 0.407
34 SMIM2-AS1 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-125a-3p;hsa-miR-132-3p;hsa-miR-148b-3p;hsa-miR-148b-5p;hsa-miR-149-5p;hsa-miR-155-5p;hsa-miR-17-5p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-181c-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-212-3p;hsa-miR-2355-5p;hsa-miR-301a-3p;hsa-miR-629-3p;hsa-miR-877-5p 20 AR Sponge network -0.66 0.00587 -2.655 0 0.407
35 AC005550.3 hsa-miR-132-3p;hsa-miR-149-5p;hsa-miR-17-5p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-181c-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-212-3p;hsa-miR-301a-3p;hsa-miR-320a;hsa-miR-338-3p;hsa-miR-362-3p;hsa-miR-629-3p 15 AR Sponge network -2.571 0.00132 -2.655 0 0.404
36 RP11-685F15.1 hsa-miR-106b-5p;hsa-miR-132-3p;hsa-miR-148b-3p;hsa-miR-148b-5p;hsa-miR-17-5p;hsa-miR-181b-5p;hsa-miR-185-5p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-301a-3p;hsa-miR-320a;hsa-miR-362-3p;hsa-miR-452-3p;hsa-miR-454-3p;hsa-miR-93-5p 15 AR Sponge network -9.951 0 -2.655 0 0.404
37 RP11-115J16.1 hsa-miR-125a-3p;hsa-miR-132-3p;hsa-miR-146a-5p;hsa-miR-155-5p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-181c-5p;hsa-miR-185-5p;hsa-miR-200a-5p;hsa-miR-212-3p;hsa-miR-2355-3p;hsa-miR-2355-5p;hsa-miR-301a-3p;hsa-miR-421;hsa-miR-877-5p;hsa-miR-93-5p 16 AR Sponge network -2.038 7.0E-5 -2.655 0 0.401
38 RP11-21L23.2 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-125a-3p;hsa-miR-136-5p;hsa-miR-141-3p;hsa-miR-146a-5p;hsa-miR-148b-5p;hsa-miR-17-5p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-181c-5p;hsa-miR-200a-3p;hsa-miR-200a-5p;hsa-miR-2355-3p;hsa-miR-301a-3p;hsa-miR-335-3p;hsa-miR-370-3p;hsa-miR-454-3p;hsa-miR-877-5p;hsa-miR-93-5p 20 AR Sponge network -0.423 0.23457 -2.655 0 0.382
39 AP000473.5 hsa-miR-106b-5p;hsa-miR-125a-3p;hsa-miR-132-3p;hsa-miR-148b-5p;hsa-miR-17-5p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-181c-5p;hsa-miR-185-5p;hsa-miR-20a-5p;hsa-miR-212-3p;hsa-miR-301a-3p;hsa-miR-877-5p 13 AR Sponge network -1.157 0.00884 -2.655 0 0.378
40 RP11-116D2.1 hsa-miR-106b-5p;hsa-miR-125a-3p;hsa-miR-132-3p;hsa-miR-149-5p;hsa-miR-155-5p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-181c-5p;hsa-miR-212-3p;hsa-miR-2355-3p;hsa-miR-2355-5p;hsa-miR-301a-3p;hsa-miR-421;hsa-miR-454-3p 14 AR Sponge network -1.423 2.0E-5 -2.655 0 0.37
41 RP11-307C12.13 hsa-miR-106b-5p;hsa-miR-125a-3p;hsa-miR-132-3p;hsa-miR-146a-5p;hsa-miR-149-5p;hsa-miR-155-5p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-181c-5p;hsa-miR-200a-5p;hsa-miR-2355-3p;hsa-miR-301a-3p;hsa-miR-421 13 AR Sponge network -0.492 0.23616 -2.655 0 0.368
42 RP4-601P9.2 hsa-miR-125a-3p;hsa-miR-132-3p;hsa-miR-141-3p;hsa-miR-149-5p;hsa-miR-155-5p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-181c-5p;hsa-miR-212-3p;hsa-miR-223-3p;hsa-miR-2355-3p;hsa-miR-2355-5p;hsa-miR-335-3p 13 AR Sponge network -1.638 0.0053 -2.655 0 0.363
43 RP11-545I5.3 hsa-miR-136-3p;hsa-miR-136-5p;hsa-miR-17-5p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-2355-3p;hsa-miR-301a-3p;hsa-miR-370-3p;hsa-miR-93-5p 12 AR Sponge network 0.139 0.66524 -2.655 0 0.361
44 MAGI2-AS3 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-148b-3p;hsa-miR-149-5p;hsa-miR-17-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-301a-3p;hsa-miR-30d-5p;hsa-miR-362-3p;hsa-miR-421;hsa-miR-452-3p;hsa-miR-454-3p;hsa-miR-629-3p;hsa-miR-660-5p;hsa-miR-877-5p;hsa-miR-9-5p;hsa-miR-93-5p 19 AR Sponge network -1.801 0 -2.655 0 0.361
45 RP11-1151B14.3 hsa-miR-125a-3p;hsa-miR-132-3p;hsa-miR-149-5p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-181c-5p;hsa-miR-212-3p;hsa-miR-2355-3p;hsa-miR-2355-5p;hsa-miR-335-3p 10 AR Sponge network -0.37 0.37195 -2.655 0 0.35
46 RP11-153K11.3 hsa-miR-106b-5p;hsa-miR-125a-3p;hsa-miR-132-3p;hsa-miR-149-5p;hsa-miR-212-3p;hsa-miR-2355-3p;hsa-miR-2355-5p;hsa-miR-301a-3p;hsa-miR-338-3p;hsa-miR-93-5p 10 AR Sponge network -2.698 1.0E-5 -2.655 0 0.348
47 RP1-27K12.2 hsa-miR-106b-5p;hsa-miR-17-5p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-19a-3p;hsa-miR-200a-5p;hsa-miR-20a-5p;hsa-miR-20b-5p;hsa-miR-301a-3p;hsa-miR-320a;hsa-miR-335-3p;hsa-miR-338-3p;hsa-miR-493-5p;hsa-miR-93-5p 14 AR Sponge network -0.954 0.22875 -2.655 0 0.343
48 RP11-736K20.6 hsa-miR-132-3p;hsa-miR-148b-5p;hsa-miR-17-5p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-181c-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-212-3p;hsa-miR-301a-3p;hsa-miR-370-3p 12 AR Sponge network -0.197 0.37494 -2.655 0 0.342
49 ALDH1L1-AS2 hsa-miR-106b-5p;hsa-miR-125a-3p;hsa-miR-132-3p;hsa-miR-141-3p;hsa-miR-146a-5p;hsa-miR-149-5p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-181c-5p;hsa-miR-200a-3p;hsa-miR-200a-5p;hsa-miR-212-3p;hsa-miR-223-3p;hsa-miR-2355-3p;hsa-miR-2355-5p;hsa-miR-301a-3p;hsa-miR-335-3p;hsa-miR-454-3p;hsa-miR-93-5p 19 AR Sponge network 0.116 0.79006 -2.655 0 0.338
50 RP11-289F5.1 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-148b-3p;hsa-miR-155-5p;hsa-miR-17-5p;hsa-miR-181b-5p;hsa-miR-185-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-20b-5p;hsa-miR-320a 12 AR Sponge network -6.122 0 -2.655 0 0.329
51 ADORA2A-AS1 hsa-miR-125a-3p;hsa-miR-132-3p;hsa-miR-155-5p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-181c-5p;hsa-miR-200a-5p;hsa-miR-212-3p;hsa-miR-223-3p;hsa-miR-2355-3p 10 AR Sponge network -0.026 0.92692 -2.655 0 0.317
52 CTD-2034I21.2 hsa-miR-106b-5p;hsa-miR-125a-3p;hsa-miR-132-3p;hsa-miR-155-5p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-20b-5p;hsa-miR-301a-3p;hsa-miR-877-5p;hsa-miR-93-5p 10 AR Sponge network -1.308 0.02535 -2.655 0 0.315
53 PRKAG2-AS1 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-125a-3p;hsa-miR-132-3p;hsa-miR-136-5p;hsa-miR-146a-5p;hsa-miR-148b-5p;hsa-miR-155-5p;hsa-miR-17-5p;hsa-miR-212-3p;hsa-miR-2355-3p;hsa-miR-2355-5p;hsa-miR-301a-3p;hsa-miR-421 14 AR Sponge network 0.134 0.6277 -2.655 0 0.305
54 RP11-138H11.1 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-125a-3p;hsa-miR-136-3p;hsa-miR-136-5p;hsa-miR-149-5p;hsa-miR-17-5p;hsa-miR-20a-5p;hsa-miR-2355-3p;hsa-miR-629-3p 10 AR Sponge network 0.833 0.28966 -2.655 0 0.304
55 RP11-7F17.3 hsa-miR-106b-5p;hsa-miR-132-3p;hsa-miR-155-5p;hsa-miR-17-5p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-181c-5p;hsa-miR-19a-3p;hsa-miR-200a-5p;hsa-miR-20a-5p;hsa-miR-301a-3p 11 AR Sponge network -0.873 0.00204 -2.655 0 0.3
56 LINC00570 hsa-miR-125a-3p;hsa-miR-132-3p;hsa-miR-149-5p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-181c-5p;hsa-miR-185-5p;hsa-miR-200a-5p;hsa-miR-20a-5p;hsa-miR-212-3p;hsa-miR-338-3p 11 AR Sponge network -1.088 0.05247 -2.655 0 0.278
57 RP11-736K20.5 hsa-miR-132-3p;hsa-miR-146a-5p;hsa-miR-148b-3p;hsa-miR-148b-5p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-185-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-301a-3p;hsa-miR-432-5p;hsa-miR-629-3p 13 AR Sponge network -0.26 0.20252 -2.655 0 0.26
58 RP11-798K3.2 hsa-miR-125a-3p;hsa-miR-132-3p;hsa-miR-136-5p;hsa-miR-146a-5p;hsa-miR-149-5p;hsa-miR-155-5p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-181c-5p;hsa-miR-212-3p;hsa-miR-223-3p;hsa-miR-2355-3p;hsa-miR-2355-5p 13 AR Sponge network 0.54 0.09253 -2.655 0 0.253

Quest ID: 983331eadcc8337e0662c11b8d514a02